1 | (minus)-L-alpha-hydrazino-3,4-dihydroxy-alpha-methylbenzenepropanoic acid monohydrate | - | - | - | - | 1件: 6 6 💬 |
2 | 10 mg Natura-alpha capsule | - | - | - | - | 1件: 97 97 💬 |
3 | 1[(6- Allyl- 8beta- erg | - | - | - | - | 1件: 6 6 💬 |
4 | 1[(6- Allyl- 8beta- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]- | - | - | - | - | 1件: 6 6 💬 |
5 | 1[(6- Allyl- 8beta- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]- 3- ethylurea | - | - | - | - | 1件: 6 6 💬 |
6 | 1[(6- Allyl- 8ß- erg | - | - | - | - | 1件: 6 6 💬 |
7 | 1[(6- Allyl- 8ß- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]- | - | - | - | - | 1件: 6 6 💬 |
8 | 1[(6- Allyl- 8ß- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]- 3- ethylurea | - | - | - | - | 1件: 6 6 💬 |
9 | 2 x 10 mg Natura-alpha capsules | - | - | - | - | 1件: 97 97 💬 |
10 | 3-(3,4-Dihydroxyphenyl)-L-alanine | 1件: Alanine Alanine | 1件: Alanine
Alanine
💬 | - | - | 1件: 6 6 💬 |
11 | 40 mg QD Alogabat | - | - | - | - | 1件: 201 201 💬 |
12 | 40 MG- SOLUZIONE INIETTABILE IN SIRINGHE PRE-RIEMPITE- USO SOTTOCUTANEO- SIRINGA PRERIEMPITA (0,4ML)- 2 SIRINGHE PRE-RIEMPITE + 2 TAMPONI IMBEVUTI DI ALCOOL | - | - | - | - | 1件: 107 107 💬 |
13 | 5-ALA | 1件: Aminolevulinic acid Aminolevulinic acid (5-ALA) | 1件: Aminolevulinic acid
Aminolevulinic acid
💬 | - | - | 1件: 180 180 💬 |
14 | 6 alpha-ethylchenodeoxycholic acid (6-EDCA), OCA, INT-747 | - | - | - | - | 1件: 93 93 💬 |
15 | 60 mg QD Alogabat | - | - | - | - | 1件: 201 201 💬 |
16 | 7 mg QD Alogabat | - | - | - | - | 1件: 201 201 💬 |
17 | 89 Zirconium Recombinant Human Alpha-N-Acetylglucosaminidase (rhNAGLU) (radiolabeled) | - | - | - | - | 1件: 19 19 💬 |
18 | 89ZR-BEVACIZUMAB (ALYMSYS) | 2件: Bevacizumab Bevacizumab (Alymsys), Bevacizumab zirconium Zr-89 | 1件: Bevacizumab
Bevacizumab
(ALYMSYS) 💬 | 1件: VEGFA VEGFA 💬 | 24件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬 | 1件: 34 34 💬 |
19 | 90 mg hydrocortisone acetate suppository with Sephure suppository applicator (ALKINDI) | 3件: Acetate Acetate, Hydrocortisone (Meijer Anti-itch with Aloe), Hydrocortisone acetate (Alumier MD Post Procedure Kit with Hydrocortisone) | 2件: Hydrocortisone
Hydrocortisone
(ALKINDI),
Hydrocortisone acetate
💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 💬 |
20 | 98% dehydrated alcohol | 1件: Ethanol Ethanol (Integrity Made LLC Aloe Scent with Vitamin E HANDSANITIZER) | 1件: Ethanol
Ethanol
💬 | - | - | 1件: 298 298 💬 |
21 | Abatacept also known as Orencia also known as CTLA4-Ig | 1件: Abatacept Abatacept | 1件: Abatacept
Abatacept
💬 | 2件: CD80 CD80, CD86 💬 | 13件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | 1件: 49 49 💬 |
22 | ADEMPAS - 0,5 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PP/ALU) - 42 COMPRESSE | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬 | 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬 |
23 | ADEMPAS - 1 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PP/ALU) - 42 COMPRESSE | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬 | 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 2件: 51 51, 86 💬 |
24 | ADEMPAS - 1,5 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PP/ALU) - 42 COMPRESSE | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬 | 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 2件: 51 51, 86 💬 |
25 | ADEMPAS - 2 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PP/ALU) - 42 COMPRESSE | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬 | 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 2件: 51 51, 86 💬 |
26 | ADEMPAS - 2,5 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PP/ALU) - 42 COMPRESSE | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬 | 3件: GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 2件: 51 51, 86 💬 |
27 | Adeno-associated viral vector serotype 9 containing the human N-acetyl-alpha-glucosaminidase gene | - | - | - | - | 1件: 19 19 💬 |
28 | Adeno-associated virus serotype 2/6 encoding human alpha-galactosidase A cDNA | 1件: Agalsidase alfa Agalsidase alfa | 1件: Agalsidase alfa
Agalsidase alfa
💬 | 1件: GLA GLA 💬 | 6件: Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬 | 1件: 19 19 💬 |
29 | Adipose derived allogenic mesenchymal stem cells (adAMSC) | - | - | - | - | 1件: 96 96 💬 |
30 | Aerosolized human Alpha-1 Antitrypsin | - | - | - | - | 1件: 231 231 💬 |
31 | Aerosolized, human, plasma-derived Alpha-1 Antitrypsin | - | - | - | - | 1件: 299 299 💬 |
32 | AGALSIDASE ALFA | 1件: Agalsidase alfa Agalsidase alfa | 1件: Agalsidase alfa
Agalsidase alfa
💬 | 1件: GLA GLA 💬 | 6件: Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬 | 1件: 19 19 💬 |
33 | Agalsidase Alpha | 1件: Agalsidase alfa Agalsidase alfa | 1件: Agalsidase alfa
Agalsidase alfa
💬 | 1件: GLA GLA 💬 | 6件: Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬 | 1件: 19 19 💬 |
34 | AGALSIDASI ALFA | - | - | - | - | 1件: 19 19 💬 |
35 | AL | - | - | - | - | 11件: 5 5, 6, 7, 13, 28, 51, 67, 86, 97, 114, 127 💬 |
36 | AL-108 | - | - | - | - | 1件: 5 5 💬 |
37 | AL001 | 1件: Latozinemab Latozinemab (AL001) | 1件: Latozinemab
Latozinemab
💬 | 1件: SORT1 SORT1 💬 | 3件: Cholesterol metabolism Cholesterol metabolism, Lysosome, Neurotrophin signaling pathway 💬 | 2件: 2 2, 127 💬 |
38 | AL01211 | - | - | - | - | 1件: 67 67 💬 |
39 | AL2846 capsules | - | - | - | - | 1件: 34 34 💬 |
40 | ALA | - | - | - | - | 2件: 180 180, 286 💬 |
41 | ALAC, inulin, FOS, and sodium butyrate | 2件: Butyric Acid Butyric Acid, Inulin | 1件: Inulin
Inulin
💬 | - | - | 1件: 156 156 💬 |
42 | Alanine | 1件: Alanine Alanine | 1件: Alanine
Alanine
💬 | - | - | 4件: 6 6, 13, 298, 299 💬 |
43 | Albendazole | 1件: Albendazole Albendazole | 1件: Albendazole
Albendazole
💬 | - | - | 1件: 96 96 💬 |
44 | Albendazole (Eskazole) | 1件: Albendazole Albendazole | 1件: Albendazole
Albendazole
💬 | - | - | 1件: 96 96 💬 |
45 | Albumen | 1件: Egg white Egg white (Egg white allergenic extract) | - | - | - | 1件: 96 96 💬 |
46 | Albumin | - | - | - | - | 3件: 2 2, 20, 51 💬 |
47 | Albumin (Human) 20%, United States Pharmacopeia (USP) | - | - | - | - | 1件: 231 231 💬 |
48 | Albumin (Human) 25%, United States Pharmacopeia (USP) | - | - | - | - | 2件: 13 13, 14 💬 |
49 | Albumin solution | - | - | - | - | 1件: 20 20 💬 |
50 | ALBUMINE HUMAINE | - | - | - | - | 1件: 96 96 💬 |
51 | Albunorm® 5%, | - | - | - | - | 1件: 20 20 💬 |
52 | Albutein 5% | 1件: Albumin human Albumin human | 1件: Albumin human
Albumin human
💬 | - | - | 1件: 2 2 💬 |
53 | Albuterol | 1件: Salbutamol Salbutamol (Albuterol sulfate) | 1件: Albuterol
Albuterol
💬 | 1件: ADRB2 ADRB2 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 7件: 12 12, 13, 86, 89, 113, 256, 299 💬 |
54 | Albuterol inhaler | 1件: Salbutamol Salbutamol (Albuterol sulfate) | 1件: Albuterol
Albuterol
💬 | 1件: ADRB2 ADRB2 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 89 89 💬 |
55 | Albuterol nebulizer | 1件: Salbutamol Salbutamol (Albuterol sulfate) | 1件: Albuterol
Albuterol
💬 | 1件: ADRB2 ADRB2 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 89 89 💬 |
56 | Albuterol. | 1件: Salbutamol Salbutamol (Albuterol sulfate) | 1件: Albuterol
Albuterol
💬 | 1件: ADRB2 ADRB2 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬 |
57 | Albutropin | - | - | - | - | 1件: 78 78 💬 |
58 | Albúmina humana | - | - | - | - | 1件: 2 2 💬 |
59 | Alcohol | 1件: Ethanol Ethanol (Integrity Made LLC Aloe Scent with Vitamin E HANDSANITIZER) | 1件: Ethanol
Ethanol
💬 | - | - | 3件: 58 58, 279, 298 💬 |
60 | ALD518 | - | - | - | - | 1件: 46 46 💬 |
61 | ALD518 monoclonal antibody (anti IL-6 mAb) | - | - | - | - | 1件: 46 46 💬 |
62 | ALDESLEUCHINA | - | - | - | - | 1件: 49 49 💬 |
63 | ALDESLEUKIN | 1件: Aldesleukin Aldesleukin | 1件: Aldesleukin
Aldesleukin
💬 | 3件: IL2RA IL2RA, IL2RB, IL2RG 💬 | 14件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬 | 4件: 49 49, 65, 96, 97 💬 |
64 | Aldosterone | 1件: Aldosterone Aldosterone | 1件: Aldosterone
Aldosterone
💬 | 1件: NR3C2 NR3C2 💬 | 1件: Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption 💬 | 1件: 222 222 💬 |
65 | Aldurazyme | 1件: Laronidase Laronidase (alpha-L-Idosiduronase) | 1件: Laronidase
Laronidase
(Aldurazyme (TN)) 💬 | 1件: IDUA IDUA 💬 | 3件: Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | 1件: 19 19 💬 |
66 | Aldurazyme (laronidase) | 1件: Laronidase Laronidase (alpha-L-Idosiduronase) | 1件: Laronidase
Laronidase
(Aldurazyme (TN)) 💬 | 1件: IDUA IDUA 💬 | 3件: Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | 2件: 19 19, 256 💬 |
67 | Aldurazyme (Recombinant Human Alpha-L-Iduronidase) | 1件: Laronidase Laronidase (alpha-L-Idosiduronase) | 1件: Laronidase
Laronidase
(Aldurazyme (TN)) 💬 | 1件: IDUA IDUA 💬 | 3件: Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | 1件: 19 19 💬 |
68 | ALDURAZYME*INFUS 1FL 5ML 500U | 1件: Laronidase Laronidase (alpha-L-Idosiduronase) | 1件: Laronidase
Laronidase
(Aldurazyme (TN)) 💬 | 1件: IDUA IDUA 💬 | 3件: Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | 1件: 19 19 💬 |
69 | Alefacept | 1件: Alefacept Alefacept | 1件: Alefacept
Alefacept
💬 | 1件: CD58 CD58 💬 | 2件: Cell adhesion molecules Cell adhesion molecules, Epstein-Barr virus infection 💬 | 6件: 37 37, 60, 65, 164, 284, 285 💬 |
70 | ALEMTUZUMAB | 1件: Alemtuzumab Alemtuzumab | 1件: Alemtuzumab
Alemtuzumab
💬 | 1件: CD52 CD52 💬 | - | 17件: 13 13, 15, 19, 20, 36, 43, 44, 46, 51, 60, 63, 65, 85, 96, 164, 283, 284 💬 |
71 | Alemtuzumab (already received by alemtuzumab cohort between 1991 and 1994 | 1件: Alemtuzumab Alemtuzumab | 1件: Alemtuzumab
Alemtuzumab
💬 | 1件: CD52 CD52 💬 | - | 1件: 46 46 💬 |
72 | Alemtuzumab (already received by alemtuzumab cohort between 1991 and 1994) | 1件: Alemtuzumab Alemtuzumab | 1件: Alemtuzumab
Alemtuzumab
💬 | 1件: CD52 CD52 💬 | - | 1件: 46 46 💬 |
73 | Alemtuzumab (Campath ) | 1件: Alemtuzumab Alemtuzumab | 1件: Alemtuzumab
Alemtuzumab
💬 | 1件: CD52 CD52 💬 | - | 1件: 60 60 💬 |
74 | Alemtuzumab (Campath) | 1件: Alemtuzumab Alemtuzumab | 1件: Alemtuzumab
Alemtuzumab
💬 | 1件: CD52 CD52 💬 | - | 1件: 15 15 💬 |
75 | Alemtuzumab (GZ402673) | 1件: Alemtuzumab Alemtuzumab | 1件: Alemtuzumab
Alemtuzumab
💬 | 1件: CD52 CD52 💬 | - | 1件: 13 13 💬 |
76 | Alemtuzumab 0.2 mg | 1件: Alemtuzumab Alemtuzumab | 1件: Alemtuzumab
Alemtuzumab
💬 | 1件: CD52 CD52 💬 | - | 2件: 65 65, 164 💬 |
77 | Alemtuzumab 0.3 mg | 1件: Alemtuzumab Alemtuzumab | 1件: Alemtuzumab
Alemtuzumab
💬 | 1件: CD52 CD52 💬 | - | 2件: 65 65, 164 💬 |
78 | Alemtuzumab 12 mg | 1件: Alemtuzumab Alemtuzumab | 1件: Alemtuzumab
Alemtuzumab
💬 | 1件: CD52 CD52 💬 | - | 1件: 13 13 💬 |
79 | Alemtuzumab 24 mg | 1件: Alemtuzumab Alemtuzumab | 1件: Alemtuzumab
Alemtuzumab
💬 | 1件: CD52 CD52 💬 | - | 1件: 13 13 💬 |
80 | Alemtuzumab and Rituximab | 2件: Alemtuzumab Alemtuzumab, Rituximab | 2件: Alemtuzumab
Alemtuzumab
,
Rituximab
💬 | 2件: CD52 CD52, MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 60 60 💬 |
81 | Alemtuzumab GZ402673 | 1件: Alemtuzumab Alemtuzumab | 1件: Alemtuzumab
Alemtuzumab
💬 | 1件: CD52 CD52 💬 | - | 1件: 13 13 💬 |
82 | Alemtuzumab immunotherapy | 1件: Alemtuzumab Alemtuzumab | 1件: Alemtuzumab
Alemtuzumab
💬 | 1件: CD52 CD52 💬 | - | 1件: 13 13 💬 |
83 | Alemtuzumab Injection | 1件: Alemtuzumab Alemtuzumab | 1件: Alemtuzumab
Alemtuzumab
💬 | 1件: CD52 CD52 💬 | - | 1件: 13 13 💬 |
84 | Alemtuzumab Injection [Lemtrada] | 1件: Alemtuzumab Alemtuzumab | 1件: Alemtuzumab
Alemtuzumab
💬 | 1件: CD52 CD52 💬 | - | 1件: 13 13 💬 |
85 | Alemtuzumab, Rituximab | 2件: Alemtuzumab Alemtuzumab, Rituximab | 2件: Alemtuzumab
Alemtuzumab
,
Rituximab
💬 | 2件: CD52 CD52, MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 63 63 💬 |
86 | Alendronat Teva | - | - | - | - | 1件: 46 46 💬 |
87 | Alendronate | 1件: Alendronic acid Alendronic acid | 1件: Alendronic acid
Alendronic acid
💬 | 1件: FDPS FDPS 💬 | 4件: Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 7件: 19 19, 41, 46, 50, 271, 274, 299 💬 |
88 | Alendronate sodium | 1件: Alendronic acid Alendronic acid | 1件: Alendronic acid
Alendronic acid
💬 | 1件: FDPS FDPS 💬 | 4件: Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 2件: 19 19, 299 💬 |
89 | Alendronate versus alfacalcidol (1-alpha OH vitamin D) | 3件: Alendronic acid Alendronic acid, Alfacalcidol, Vitamin D | 2件: Alfacalcidol
Alfacalcidol
,
Alendronic acid
💬 | 2件: FDPS FDPS, VDR 💬 | 9件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Terpenoid backbone biosynthesis, Tuberculosis 💬 | 3件: 41 41, 46, 50 💬 |
90 | ALENDRONIC ACID | 1件: Alendronic acid Alendronic acid | 1件: Alendronic acid
Alendronic acid
💬 | 1件: FDPS FDPS 💬 | 4件: Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 2件: 46 46, 274 💬 |
91 | Alequel | - | - | - | - | 1件: 96 96 💬 |
92 | Alfa-manosidadas humana recombinante | - | - | - | - | 1件: 19 19 💬 |
93 | Alfacalcidol | 1件: Alfacalcidol Alfacalcidol | 1件: Alfacalcidol
Alfacalcidol
💬 | 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 8件: 41 41, 46, 49, 50, 96, 107, 235, 238 💬 |
94 | Alfacalcidol 2 micrograms/ml | 1件: Alfacalcidol Alfacalcidol | 1件: Alfacalcidol
Alfacalcidol
💬 | 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 2件: 50 50, 107 💬 |
95 | Alfuzosin | 1件: Alfuzosin Alfuzosin | 1件: Alfuzosin
Alfuzosin
💬 | 1件: ADRA1A ADRA1A 💬 | 7件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 13 13 💬 |
96 | Alga Dunaliella Bardawil | - | - | - | - | 1件: 90 90 💬 |
97 | Alga Dunaliella Bardawil powder | - | - | - | - | 1件: 90 90 💬 |
98 | Alga Dunaliella Bardawill | - | - | - | - | 1件: 90 90 💬 |
99 | Algin | 1件: Alginic acid Alginic acid | 1件: Alginic acid
Alginic acid
💬 | - | - | 1件: 97 97 💬 |
100 | Alginate | 1件: Alginic acid Alginic acid | 1件: Alginic acid
Alginic acid
💬 | - | - | 2件: 53 53, 299 💬 |
101 | Alginate oligosaccharide | 1件: Alginic acid Alginic acid | 1件: Alginic acid
Alginic acid
💬 | - | - | 1件: 299 299 💬 |
102 | Alginic acid | 1件: Alginic acid Alginic acid | 1件: Alginic acid
Alginic acid
💬 | - | - | 1件: 51 51 💬 |
103 | ALGLUCOSIDASE ALFA | 1件: Alglucosidase alfa Alglucosidase alfa | 1件: Alglucosidase alfa
Alglucosidase alfa
💬 | 1件: GAA GAA 💬 | 4件: Galactose metabolism Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬 | 1件: 256 256 💬 |
104 | Alglucosidase Alfa (Genetical Recombination) | 1件: Alglucosidase alfa Alglucosidase alfa | 1件: Alglucosidase alfa
Alglucosidase alfa
💬 | 1件: GAA GAA 💬 | 4件: Galactose metabolism Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬 | 1件: 256 256 💬 |
105 | Alglucosidase alfa (GZ419829) | 1件: Alglucosidase alfa Alglucosidase alfa | 1件: Alglucosidase alfa
Alglucosidase alfa
💬 | 1件: GAA GAA 💬 | 4件: Galactose metabolism Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬 | 1件: 256 256 💬 |
106 | ALGLUCOSIDASE ALFA (MYOZYME) | 1件: Alglucosidase alfa Alglucosidase alfa | 1件: Alglucosidase alfa
Alglucosidase alfa
💬 | 1件: GAA GAA 💬 | 4件: Galactose metabolism Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬 | 1件: 256 256 💬 |
107 | Alglucosidase alfa (recombinant human acid alpha-glucosidase [rhGAA]) | 1件: Alglucosidase alfa Alglucosidase alfa | 1件: Alglucosidase alfa
Alglucosidase alfa
💬 | 1件: GAA GAA 💬 | 4件: Galactose metabolism Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬 | 1件: 256 256 💬 |
108 | Alglucosidase alfa GZ419829 | 1件: Alglucosidase alfa Alglucosidase alfa | 1件: Alglucosidase alfa
Alglucosidase alfa
💬 | 1件: GAA GAA 💬 | 4件: Galactose metabolism Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬 | 1件: 256 256 💬 |
109 | Alglucosidase alpha | - | - | - | - | 1件: 256 256 💬 |
110 | ALGLUCOSIDASI ALFA UMANA RICOMBINANTE | - | - | - | - | 1件: 256 256 💬 |
111 | Alicaforsen | 1件: Alicaforsen Alicaforsen | - | - | - | 2件: 96 96, 97 💬 |
112 | Alicalm (polymeric liquid formula) | - | - | - | - | 1件: 96 96 💬 |
113 | ALIROCUMAB | 1件: Alirocumab Alirocumab | 1件: Alirocumab
Alirocumab
💬 | 1件: PCSK9 PCSK9 💬 | 1件: Cholesterol metabolism Cholesterol metabolism 💬 | 1件: 79 79 💬 |
114 | Alirocumab SAR236553 (REGN727) | 1件: Alirocumab Alirocumab | 1件: Alirocumab
Alirocumab
💬 | 1件: PCSK9 PCSK9 💬 | 1件: Cholesterol metabolism Cholesterol metabolism 💬 | 1件: 79 79 💬 |
115 | ALISERIN - 25 MG GRANULATO EFFERVESCENTE 20 BUSTINE | - | - | - | - | 1件: 19 19 💬 |
116 | Aliskiren | 1件: Aliskiren Aliskiren | 1件: Aliskiren
Aliskiren
💬 | 1件: REN REN 💬 | 3件: Diabetic cardiomyopathy Diabetic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | 3件: 66 66, 167, 222 💬 |
117 | ALITRETINOIN | 1件: Alitretinoin Alitretinoin | 1件: Alitretinoin
Alitretinoin
💬 | 5件: RARA RARA, RARB, RXRA, RXRB, RXRG 💬 | 19件: Acute myeloid leukemia Acute myeloid leukemia, Adipocytokine signaling pathway, Bile secretion, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Gastric cancer, Hepatitis C, Lipid and atherosclerosis, Non-alcoholic fatty liver disease, Non-small cell lung cancer, PI3K-Akt signaling pathway, PPAR signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer 💬 | 1件: 49 49 💬 |
118 | ALK-001 | - | - | - | - | 1件: 301 301 💬 |
119 | ALK-001 (No generic name) | - | - | - | - | 1件: 301 301 💬 |
120 | Alkaline Phosphatase | 1件: Alkaline Phosphatase Alkaline Phosphatase | - | - | - | 4件: 46 46, 93, 97, 172 💬 |
121 | Alkalinized Lidocaine-Heparin | 2件: Heparin Heparin, Lidocaine (Alocane Emergency Burn Pads) | 3件: Lidocaine
Lidocaine
,
Adomiparin
,
Lidocaine hydrochloride monohydrate
💬 | 6件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SERPINC1 💬 | 4件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Complement and coagulation cascades, Dopaminergic synapse, Taste transduction 💬 | 1件: 226 226 💬 |
122 | ALKERAN | 1件: Melphalan Melphalan (Alkeran) | 1件: Melphalan
Melphalan
(Alkeran (TN)) 💬 | - | - | 2件: 28 28, 60 💬 |
123 | ALKS 8700 | - | - | - | - | 1件: 13 13 💬 |
124 | ALKS 8700 Delayed Release (DR) | 1件: Manganese citrate Manganese citrate | - | - | - | 1件: 13 13 💬 |
125 | ALKS 8700 Delayed Release (DR) Capsule | 1件: Manganese citrate Manganese citrate | - | - | - | 1件: 13 13 💬 |
126 | All patients in the study will be treated with ocrelizumab | 1件: Ocrelizumab Ocrelizumab | 1件: Ocrelizumab
Ocrelizumab
💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 💬 |
127 | All subjects will receive maraviroc 300mg orally twice a day for 6 weeks | 1件: Maraviroc Maraviroc | 1件: Maraviroc
Maraviroc
💬 | 1件: CCR5 CCR5 💬 | 11件: Chemokine signaling pathway Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Toxoplasmosis, Viral carcinogenesis, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬 | 1件: 84 84 💬 |
128 | All-P-ambo-2'-O-(2-methoxyethyl)-P-thioguanylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-5-methylcytidylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)adenylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)adenylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-5-methyluridylyl-(3'-O->5'-O)-2'-deoxy-P-thioguanylyl-(3'-O->5'-O)-P-thiothymidylyl-(3'-O->5'-O)-2'-deoxy-5-methyl-P-thiocytidylyl-(3'-O->5'-O)-2'-deoxy-P-thioadenylyl-(3'-O->5'-O)-2'-deoxy-5-methyl-P-thiocytidylyl-(3'-O->5'-O)-2'-deoxy-5-methyl-P-thiocytidylyl-(3'-O->5'-O)-P-thiothymidylyl-(3'-O->5'-O)-P-thiothymidylyl-(3'-O->5'-O)-P-thiothymidylyl-(3'-O->5'-O)-2'-deoxy-5-methyl-P-thiocytidylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)adenylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-5-methyluridylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-P-thioadenylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-5-methyl-P-thiocytidylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-5-methylcytidine | - | - | - | - | 1件: 2 2 💬 |
129 | All-P-ambo-2'-O-(2-methoxyethyl)-P-thioguanylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-5-methylcytidylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)adenylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)adenylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-5-methyluridylyl-(3'-O->5'-O)-2'-deoxy-P-thioguanylyl-(3'-O->5'-O)-P-thiothymidylyl-(3'-O->5'-O)-2'-deoxy-5-methyl-P-thiocytidylyl-(3'-O->5'-O)-2'-deoxy-Pthioadenylyl-(3'-O->5'-O)-2'-deoxy-5-methyl-P-thiocytidylyl-(3'-O->5'-O)-2'-deoxy- | - | - | - | - | 1件: 2 2 💬 |
130 | All-trans retinoic acid | 1件: Tretinoin Tretinoin (all--Retinoic acid) | 1件: Tretinoin
Tretinoin
(ALTRENO) 💬 | 3件: PML PML, RARA, RARB 💬 | 12件: Acute myeloid leukemia Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis 💬 | 1件: 94 94 💬 |
131 | All-Trans Retinoid Acid(ATRA) | 1件: Tretinoin Tretinoin (all--Retinoic acid) | 1件: Tretinoin
Tretinoin
(ALTRENO) 💬 | 3件: PML PML, RARA, RARB 💬 | 12件: Acute myeloid leukemia Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis 💬 | 1件: 63 63 💬 |
132 | ALLANTOIN | 1件: Allantoin Allantoin | 1件: Allantoin
Allantoin
💬 | - | - | 1件: 36 36 💬 |
133 | ALLANTOINA | - | - | - | - | 1件: 36 36 💬 |
134 | Allergy immunotherapy (allergy shots) | - | - | - | - | 1件: 98 98 💬 |
135 | Allo-APZ2-EB | - | - | - | - | 1件: 36 36 💬 |
136 | Allo-APZ2-OTS | - | - | - | - | 1件: 36 36 💬 |
137 | ALLO-ASC | - | - | - | - | 1件: 96 96 💬 |
138 | ALLO-ASC-CD | - | - | - | - | 1件: 96 96 💬 |
139 | ALLO-ASC-DFU | - | - | - | - | 1件: 36 36 💬 |
140 | ALLO-ASC-SHEET | - | - | - | - | 1件: 36 36 💬 |
141 | Allo-hMSCs | - | - | - | - | 2件: 211 211, 299 💬 |
142 | Allo-HSCT | - | - | - | - | 1件: 20 20 💬 |
143 | AlloGen-LI | - | - | - | - | 1件: 70 70 💬 |
144 | Allogeneic adipose tissue-derived mesenchymal stem cells | - | - | - | - | 1件: 97 97 💬 |
145 | ALLOGENEIC ADIPOSE TISSUE-DERIVED MESENCHYMAL STEM CELLS EXPANDED | - | - | - | - | 5件: 36 36, 38, 53, 96, 162 💬 |
146 | Allogeneic adipose tissue-derived MSC | - | - | - | - | 1件: 36 36 💬 |
147 | Allogeneic adipose tissue-derived stromal/stem cells | - | - | - | - | 1件: 53 53 💬 |
148 | Allogeneic Adult Human Mesenchymal Stem Cells (hMSCs) | 1件: Remestemcel-L Remestemcel-L (Allogeneic human mesenchymal stem cell) | 1件: Remestemcel-L
Remestemcel-L
💬 | - | - | 1件: 85 85 💬 |
149 | Allogeneic Bone Marrow derived Human Mesenchymal Stem Cells (hMSCs) | - | - | - | - | 1件: 96 96 💬 |
150 | Allogeneic bone marrow transplant | - | - | - | - | 1件: 49 49 💬 |
151 | Allogeneic bone marrow-derived MSCs (1 x 10 6 MSC/kg) | - | - | - | - | 1件: 6 6 💬 |
152 | Allogeneic bone marrow-derived MSCs (10 x 10 6 MSC/kg) | - | - | - | - | 1件: 6 6 💬 |
153 | Allogeneic bone marrow-derived MSCs (3 x 10 6 MSC/kg) | - | - | - | - | 1件: 6 6 💬 |
154 | Allogeneic bone marrow-derived MSCs (6 x 10 6 MSC/kg) | - | - | - | - | 1件: 6 6 💬 |
155 | Allogeneic Cardiosphere-Derived Cells (CAP-1002) | 1件: CAP-1002 CAP-1002 | - | - | - | 1件: 113 113 💬 |
156 | Allogeneic donor derived B-lymphocytes | - | - | - | - | 1件: 60 60 💬 |
157 | Allogeneic Human Cardiosphere-Derived Stem Cells | - | - | - | - | 1件: 86 86 💬 |
158 | Allogeneic Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells | - | - | - | - | 1件: 13 13 💬 |
159 | ALLOGENEIC MESENCHYMAL PRECURSOR CELLS | - | - | - | - | 1件: 46 46 💬 |
160 | Allogeneic mesenchymal stem cell transplantation | - | - | - | - | 1件: 171 171 💬 |
161 | Allogeneic Mesenchymal Stem Cells | - | - | - | - | 1件: 47 47 💬 |
162 | Allogeneic Mesenchymal Stem Cells (AlloMSC) | - | - | - | - | 2件: 51 51, 53 💬 |
163 | Allogeneic mesenchymal stromal cells | 1件: Human Umbilical Cord Mesenchymal Stem Cells Human Umbilical Cord Mesenchymal Stem Cells | - | - | - | 1件: 36 36 💬 |
164 | ALLOGENEIC MESENCHYMAL STROMAL CELLS DERIVED FROM THE UMBILICAL CORD | 1件: Human Umbilical Cord Mesenchymal Stem Cells Human Umbilical Cord Mesenchymal Stem Cells | - | - | - | 1件: 49 49 💬 |
165 | Allogeneic MSC (AlloMSC) | - | - | - | - | 1件: 49 49 💬 |
166 | ALLOGENEIC NEURAL RETINA-DERIVED HUMAN NEURAL RETINAL PROGENITOR CELLS EX VIVO EXPANDED | - | - | - | - | 1件: 90 90 💬 |
167 | Allogeneic peripheral blood stem cell | - | - | - | - | 1件: 65 65 💬 |
168 | Allogeneic skin-derived ABCB5-positive mesenchymal stem cells | - | - | - | - | 1件: 36 36 💬 |
169 | Allogeneic Stem Cell Therapy | - | - | - | - | 1件: 96 96 💬 |
170 | Allogeneic Stem Cell Transplant | - | - | - | - | 2件: 53 53, 56 💬 |
171 | Allogeneic Stem Cell Transplantation | - | - | - | - | 2件: 49 49, 84 💬 |
172 | Allogeneic Umbilical Cord Mesenchymal Stem Cell and Adipose Secretome Implantation | - | - | - | - | 1件: 17 17 💬 |
173 | Allogeneic Umbilical Cord Mesenchymal Stem Cell Implantation | - | - | - | - | 1件: 17 17 💬 |
174 | Allogeneic umbilical cord mesenchymal stem cells | - | - | - | - | 1件: 13 13 💬 |
175 | Allogenic eASCs 5 milion cells/ml suspension for injection. Cx601 | - | - | - | - | 1件: 96 96 💬 |
176 | Allogenic eASCs 5 million cells/ml suspension for injection CX601 | - | - | - | - | 1件: 96 96 💬 |
177 | Allogenic eASCs 5 million cells/ml suspension for injection. CX601 | - | - | - | - | 1件: 96 96 💬 |
178 | Allogenic eASCs 5 million/ml suspension for injection. | - | - | - | - | 1件: 96 96 💬 |
179 | ALLOGENIC HUMAN HETEROLOGOUS LIVER CELLS | - | - | - | - | 1件: 251 251 💬 |
180 | Allogenic mesenchymal stem cell isolated from adipose tissue | - | - | - | - | 3件: 38 38, 96, 162 💬 |
181 | Allogenic mesenchymal stromal cells | 1件: Human Umbilical Cord Mesenchymal Stem Cells Human Umbilical Cord Mesenchymal Stem Cells | - | - | - | 1件: 36 36 💬 |
182 | Allogenic parathyroid cells | - | - | - | - | 1件: 235 235 💬 |
183 | Allopregnanolone | 1件: Brexanolone Brexanolone (Allopregnanolone) | 1件: Brexanolone
Brexanolone
💬 | 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 205 205 💬 |
184 | Allopurinol | 1件: Allopurinol Allopurinol | 1件: Allopurinol
Allopurinol
💬 | 1件: XDH XDH 💬 | 6件: Caffeine metabolism Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Peroxisome, Purine metabolism 💬 | 7件: 6 6, 46, 57, 60, 66, 96, 97 💬 |
185 | Allopurinol Sandoz 100 mg, tabletten | 1件: Allopurinol Allopurinol | 1件: Allopurinol
Allopurinol
💬 | 1件: XDH XDH 💬 | 6件: Caffeine metabolism Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Peroxisome, Purine metabolism 💬 | 1件: 96 96 💬 |
186 | ALLOPURINOL SODIUM | 1件: Allopurinol Allopurinol | 1件: Allopurinol
Allopurinol
💬 | 1件: XDH XDH 💬 | 6件: Caffeine metabolism Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Peroxisome, Purine metabolism 💬 | 1件: 96 96 💬 |
187 | AlloRx | - | - | - | - | 8件: 2 2, 6, 13, 46, 51, 85, 90, 226 💬 |
188 | ALN-51547 | - | - | - | - | 1件: 28 28 💬 |
189 | ALN-60212 | - | - | - | - | 1件: 79 79 💬 |
190 | ALN-60519 | - | - | - | - | 1件: 254 254 💬 |
191 | ALN-61444 | - | - | - | - | 1件: 231 231 💬 |
192 | ALN-62643 | - | - | - | - | 2件: 62 62, 109 💬 |
193 | ALN-65585 | - | - | - | - | 1件: 234 234 💬 |
194 | ALN-77412 | - | - | - | - | 1件: 231 231 💬 |
195 | ALN-AAT | - | - | - | - | 1件: 231 231 💬 |
196 | ALN-AAT02 | - | - | - | - | 1件: 231 231 💬 |
197 | ALN-AS1 | - | - | - | - | 1件: 254 254 💬 |
198 | ALN-CC5 | - | - | - | - | 4件: 11 11, 62, 66, 109 💬 |
199 | ALN-GO1 | - | - | - | - | 1件: 234 234 💬 |
200 | ALN-PCSSC | 1件: Inclisiran Inclisiran (ALN-PCSsc) | 1件: Inclisiran
Inclisiran
💬 | 1件: PCSK9 PCSK9 💬 | 1件: Cholesterol metabolism Cholesterol metabolism 💬 | 1件: 79 79 💬 |
201 | ALN-TTRSC | - | - | - | - | 1件: 28 28 💬 |
202 | AloASC | - | - | - | - | 1件: 97 97 💬 |
203 | Aloe | 1件: Aloe vera leaf Aloe vera leaf | - | - | - | 2件: 97 97, 226 💬 |
204 | Aloe Barbadensis Miller | 1件: Aloe vera leaf Aloe vera leaf | - | - | - | 1件: 97 97 💬 |
205 | Aloe vera | 1件: Aloe vera leaf Aloe vera leaf | - | - | - | 2件: 97 97, 226 💬 |
206 | Aloe vera gel | 1件: Aloe vera leaf Aloe vera leaf | - | - | - | 1件: 97 97 💬 |
207 | Alofisel | 1件: Darvadstrocel Darvadstrocel (Alofisel) | 1件: Darvadstrocel
Darvadstrocel
(Alofisel (TN)) 💬 | - | - | 1件: 96 96 💬 |
208 | Alogabat | - | - | - | - | 1件: 201 201 💬 |
209 | Alpelisib | 1件: Alpelisib Alpelisib | 1件: Alpelisib
Alpelisib
💬 | 1件: PIK3CA PIK3CA 💬 | 106件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, Metabolic pathways, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Platinum drug resistance, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬 | 1件: 138 138 💬 |
210 | Alpelisib (BYL719) | 1件: Alpelisib Alpelisib | 1件: Alpelisib
Alpelisib
💬 | 1件: PIK3CA PIK3CA 💬 | 106件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, Metabolic pathways, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Platinum drug resistance, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬 | 1件: 138 138 💬 |
211 | Alpha 1-Proteinase Inhibitor | 1件: Alpha-1-proteinase inhibitor Alpha-1-proteinase inhibitor | - | - | - | 1件: 231 231 💬 |
212 | Alpha 1-proteinase inhibitor (human) | 1件: Alpha-1-proteinase inhibitor Alpha-1-proteinase inhibitor | - | - | - | 1件: 231 231 💬 |
213 | Alpha beta depletion | - | - | - | - | 2件: 60 60, 284 💬 |
214 | Alpha interferon | - | - | - | - | 1件: 56 56 💬 |
215 | Alpha Lipoic Acid | 1件: Lipoic acid Lipoic acid (alpha-Lipoic acid) | - | - | - | 1件: 13 13 💬 |
216 | Alpha-1 Antitrypsin (AAT) | - | - | - | - | 1件: 231 231 💬 |
217 | Alpha-1 Antitrypsin (human) | - | - | - | - | 1件: 231 231 💬 |
218 | Alpha-1 HC 100 mg | - | - | - | - | 1件: 299 299 💬 |
219 | Alpha-1 HC 200 mg | - | - | - | - | 1件: 299 299 💬 |
220 | Alpha-1 MP | - | - | - | - | 1件: 231 231 💬 |
221 | Alpha-1 proteinase inhibitor (human) | - | - | - | - | 1件: 231 231 💬 |
222 | ALPHA-1-ANTITRYPSIN | 1件: Alpha-1-proteinase inhibitor Alpha-1-proteinase inhibitor | - | - | - | 1件: 231 231 💬 |
223 | Alpha-2C AR antagonist | - | - | - | - | 1件: 51 51 💬 |
224 | Alpha-galactosidase A | 1件: Agalsidase alfa Agalsidase alfa | 1件: Agalsidase alfa
Agalsidase alfa
💬 | 1件: GLA GLA 💬 | 6件: Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬 | 1件: 19 19 💬 |
225 | Alpha-glucosidase | 1件: Alglucosidase alfa Alglucosidase alfa | 1件: Alglucosidase alfa
Alglucosidase alfa
💬 | 1件: GAA GAA 💬 | 4件: Galactose metabolism Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬 | 1件: 256 256 💬 |
226 | ALPHA-LIPOIC ACID | 1件: Lipoic acid Lipoic acid (alpha-Lipoic acid) | - | - | - | 2件: 2 2, 13 💬 |
227 | Alpha-lipoic acid and L-acetyl carnitine | 2件: Levocarnitine Levocarnitine, Lipoic acid (alpha-Lipoic acid) | 1件: Levocarnitine
Levocarnitine
💬 | - | - | 1件: 5 5 💬 |
228 | Alpha-proteinase inhibitor | - | - | - | - | 1件: 98 98 💬 |
229 | Alpha-tocopherol | 2件: Tocopherol Tocopherol (Aloe Vera Sprayer), Vitamin E (Acti-D Alphacopherol Cap 800unit) | 2件: Vitamin E
Vitamin E
,
Tocopherol
(dl-alpha-Tocopherol) 💬 | - | - | 2件: 49 49, 206 💬 |
230 | Alpha-tocotrienol quinone | 1件: Tocotrienol Tocotrienol | - | - | - | 2件: 21 21, 156 💬 |
231 | Alpha-tocotrienolquinone | - | - | - | - | 1件: 18 18 💬 |
232 | Alpha1-antitrypsin | - | - | - | - | 1件: 13 13 💬 |
233 | Alpha1-Proteinase Inhibitor | 1件: Alpha-1-proteinase inhibitor Alpha-1-proteinase inhibitor | - | - | - | 2件: 231 231, 299 💬 |
234 | Alpha1-Proteinase Inhibitor (Human) | 1件: Alpha-1-proteinase inhibitor Alpha-1-proteinase inhibitor | - | - | - | 2件: 231 231, 299 💬 |
235 | Alphanate | 3件: Antihemophilic factor human Antihemophilic factor human (Alphanate), Beroctocog alfa, Von Willebrand factor human (Alphanate) | - | - | - | 1件: 288 288 💬 |
236 | Alphanate 1000 I.U. | 3件: Antihemophilic factor human Antihemophilic factor human (Alphanate), Beroctocog alfa, Von Willebrand factor human (Alphanate) | - | - | - | 1件: 288 288 💬 |
237 | Alphanate 1500 I.U. | 3件: Antihemophilic factor human Antihemophilic factor human (Alphanate), Beroctocog alfa, Von Willebrand factor human (Alphanate) | - | - | - | 1件: 288 288 💬 |
238 | Alphanate SD/HT | 2件: Beroctocog alfa Beroctocog alfa, Von Willebrand factor human (Alphanate) | - | - | - | 1件: 288 288 💬 |
239 | ALPHANATE*INF 1F 1000UI+F 10ML | 2件: Beroctocog alfa Beroctocog alfa, Von Willebrand factor human (Alphanate) | - | - | - | 1件: 288 288 💬 |
240 | ALPHANATE*INF 1F 1500UI+F 10ML | 2件: Beroctocog alfa Beroctocog alfa, Von Willebrand factor human (Alphanate) | - | - | - | 1件: 288 288 💬 |
241 | ALPHANATE*INF 1F 250UI+F 5ML | 2件: Beroctocog alfa Beroctocog alfa, Von Willebrand factor human (Alphanate) | - | - | - | 1件: 288 288 💬 |
242 | ALPHANATE*INF 1F 500UI+F 5ML | 2件: Beroctocog alfa Beroctocog alfa, Von Willebrand factor human (Alphanate) | - | - | - | 1件: 288 288 💬 |
243 | ALPN-101 | - | - | - | - | 1件: 49 49 💬 |
244 | Alprazolam | 1件: Alprazolam Alprazolam | 1件: Alprazolam
Alprazolam
💬 | 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 2件: 8 8, 75 💬 |
245 | Alprostadil | 1件: Alprostadil Alprostadil | 1件: Alprostadil
Alprostadil
💬 | 1件: PTGER1 PTGER1 💬 | 4件: Calcium signaling pathway Calcium signaling pathway, Human cytomegalovirus infection, Neuroactive ligand-receptor interaction, Pathways in cancer 💬 | 2件: 51 51, 70 💬 |
246 | ALRN-5281 0.015 mg/kg | - | - | - | - | 1件: 78 78 💬 |
247 | ALRN-5281 0.05 mg/kg | - | - | - | - | 1件: 78 78 💬 |
248 | ALRN-5281 0.15 mg/kg | - | - | - | - | 1件: 78 78 💬 |
249 | ALS patients genetic characterization | - | - | - | - | 1件: 2 2 💬 |
250 | Also referred to as 'MEDI2070' | - | - | - | - | 2件: 96 96, 97 💬 |
251 | Also referred to as MED2070 | - | - | - | - | 1件: 96 96 💬 |
252 | Also referred to as MEDI2070 | - | - | - | - | 2件: 96 96, 97 💬 |
253 | Alternative osteoporosis medications | - | - | - | - | 1件: 274 274 💬 |
254 | ALTH12-1:4 | - | - | - | - | 1件: 97 97 💬 |
255 | ALTH12-2:4 | - | - | - | - | 1件: 97 97 💬 |
256 | ALTRI FARMACI DEL SISTEMA NERVOSO | - | - | - | - | 1件: 13 13 💬 |
257 | Altropane | 1件: Altropane Altropane | - | - | - | 1件: 6 6 💬 |
258 | Altropane (123I) Injection | 1件: Altropane Altropane | - | - | - | 1件: 6 6 💬 |
259 | ALTROPANE® | 1件: Altropane Altropane | - | - | - | 1件: 6 6 💬 |
260 | ALTU-135 | 1件: ALTU-135 ALTU-135 | - | - | - | 1件: 299 299 💬 |
261 | ALTU-238 | - | - | - | - | 1件: 78 78 💬 |
262 | ALTUS-135 | - | - | - | - | 1件: 299 299 💬 |
263 | Aluminium | 1件: Aluminium Aluminium | - | - | - | 2件: 11 11, 46 💬 |
264 | Aluminium hydroxide | 3件: Aluminium Aluminium, Aluminum hydroxide, Hydroxide ion | 1件: Aluminum hydroxide
Aluminum hydroxide
💬 | - | - | 2件: 11 11, 46 💬 |
265 | Aluminium phosphate | 3件: Aluminium Aluminium, Aluminium phosphate, Phosphate ion | - | - | - | 1件: 46 46 💬 |
266 | Aluminum | 1件: Aluminium Aluminium | - | - | - | 1件: 11 11 💬 |
267 | Aluminum hydroxide | 3件: Aluminium Aluminium, Aluminum hydroxide, Hydroxide ion | 1件: Aluminum hydroxide
Aluminum hydroxide
💬 | - | - | 1件: 11 11 💬 |
268 | Alvarez 2 | - | - | - | - | 1件: 37 37 💬 |
269 | ALVELESTAT | 1件: Alvelestat Alvelestat | - | - | - | 1件: 231 231 💬 |
270 | Alvelestat oral tablet - dose 1 | 1件: Alvelestat Alvelestat | - | - | - | 1件: 231 231 💬 |
271 | Alvelestat oral tablet - dose 2 | 1件: Alvelestat Alvelestat | - | - | - | 1件: 231 231 💬 |
272 | Alvelestat tosylate | 1件: Alvelestat Alvelestat | - | - | - | 1件: 231 231 💬 |
273 | Alwextin cream | - | - | - | - | 1件: 36 36 💬 |
274 | ALX-0061 | - | - | - | - | 2件: 46 46, 49 💬 |
275 | ALX-0061 150 mg/mL | - | - | - | - | 1件: 49 49 💬 |
276 | ALX-0061 Nanobody | - | - | - | - | 1件: 46 46 💬 |
277 | ALX-0081 | - | - | - | - | 1件: 64 64 💬 |
278 | ALX-009 | - | - | - | - | 1件: 299 299 💬 |
279 | ALX-0600 | - | - | - | - | 1件: 96 96 💬 |
280 | ALX0081 | - | - | - | - | 1件: 64 64 💬 |
281 | ALXN1102 | - | - | - | - | 1件: 62 62 💬 |
282 | ALXN1103 | - | - | - | - | 1件: 62 62 💬 |
283 | ALXN1210 | - | - | - | - | 7件: 2 2, 11, 13, 50, 62, 66, 109 💬 |
284 | ALXN1830 | - | - | - | - | 3件: 11 11, 35, 61 💬 |
285 | ALXN1840 | - | - | - | - | 1件: 171 171 💬 |
286 | ALXN1850 | - | - | - | - | 1件: 172 172 💬 |
287 | ALXN2040 | - | - | - | - | 1件: 62 62 💬 |
288 | ALXN2040 (ACH-0144471) | - | - | - | - | 1件: 62 62 💬 |
289 | ALXN2050 | - | - | - | - | 2件: 11 11, 62 💬 |
290 | ALZT-OP1a (cromolyn) | 1件: Cromoglicic acid Cromoglicic acid (Rhinaris-CS Anti-allergic Nasal Mist) | 1件: Cromoglicic acid
Cromoglicic acid
💬 | - | - | 1件: 2 2 💬 |
291 | Ambrisentan plus Spironolactone (Aldactone (TN)) | 2件: Ambrisentan Ambrisentan, Spironolactone (Aldactone 100 mg) | 2件: Spironolactone
Spironolactone
(Aldactone (TN)),
Ambrisentan
💬 | 2件: EDNRA EDNRA, NR3C2 💬 | 8件: Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬 |
292 | Amitriptyline, fluoxetine and tramadol alone (control group) | 3件: Amitriptyline Amitriptyline, Fluoxetine, Tramadol | 3件: Fluoxetine
Fluoxetine
,
Amitriptyline
,
Tramadol
💬 | 3件: OPRM1 OPRM1, SLC6A2, SLC6A4 💬 | 5件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 78 78 💬 |
293 | Amniotic Fluid Allograft | - | - | - | - | 1件: 70 70 💬 |
294 | Anti Lymphotoxin Alpha | - | - | - | - | 1件: 46 46 💬 |
295 | Anti TNF Alfa. | - | - | - | - | 1件: 96 96 💬 |
296 | Anti TNF alpha agent | - | - | - | - | 1件: 271 271 💬 |
297 | Anti TNF alpha therapy | - | - | - | - | 1件: 271 271 💬 |
298 | Anti-GM-CSF receptor alpha | - | - | - | - | 1件: 46 46 💬 |
299 | Anti-integrin alphaV mAb | - | - | - | - | 1件: 51 51 💬 |
300 | Anti-TNF-alpha | - | - | - | - | 1件: 46 46 💬 |
301 | Anti-Tumor Necrosis Factor Alpha Drug (Product) | - | - | - | - | 1件: 46 46 💬 |
302 | Anti-tumor necrosis factor alpha monoclonal antibody | - | - | - | - | 1件: 107 107 💬 |
303 | Antituberculous therapy along with steroids | - | - | - | - | 1件: 84 84 💬 |
304 | Apadamtase alfa | 1件: Apadamtase alfa Apadamtase alfa | - | - | - | 1件: 64 64 💬 |
305 | Apademtase alfa | - | - | - | - | 1件: 64 64 💬 |
306 | Arthroscopy & saline irrigation alone | - | - | - | - | 1件: 46 46 💬 |
307 | Ascorbic Acid (Vitamin C) and Alpha-tocopherol (Vitamin E) | 3件: Ascorbic acid Ascorbic acid (Allbee With C 550 Cap), Tocopherol (Aloe Vera Sprayer), Vitamin E (Acti-D Alphacopherol Cap 800unit) | 3件: Ascorbic acid
Ascorbic acid
,
Vitamin E
,
Tocopherol
(dl-alpha-Tocopherol) 💬 | - | - | 1件: 206 206 💬 |
308 | Asfotas Alfa | - | - | - | - | 1件: 172 172 💬 |
309 | ASFOTASE ALFA | 1件: Asfotase alfa Asfotase alfa | 1件: Asfotase alfa
Asfotase alfa
💬 | 1件: ALPL ALPL 💬 | 4件: Biosynthesis of cofactors Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, Thiamine metabolism 💬 | 1件: 172 172 💬 |
310 | Asfotase Alfa (ALXN1215) | 1件: Asfotase alfa Asfotase alfa | 1件: Asfotase alfa
Asfotase alfa
💬 | 1件: ALPL ALPL 💬 | 4件: Biosynthesis of cofactors Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, Thiamine metabolism 💬 | 1件: 172 172 💬 |
311 | AUBAGIO - 14 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BISTER (ALU/ALU) PERFORATO MONODOSE - 10 X 1 COMPRESSA | 1件: Teriflunomide Teriflunomide | 1件: Teriflunomide
Teriflunomide
💬 | 1件: DHODH DHODH 💬 | 3件: Biosynthesis of cofactors Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬 | 1件: 13 13 💬 |
312 | AUBAGIO - 14 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (ALU/ALU) - 28 COMPRESSE | 1件: Teriflunomide Teriflunomide | 1件: Teriflunomide
Teriflunomide
💬 | 1件: DHODH DHODH 💬 | 3件: Biosynthesis of cofactors Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬 | 1件: 13 13 💬 |
313 | Autologous CD34+ cells transduced with the Lentiviral vector containing the human Wiskott Aldrich Sy | - | - | - | - | 1件: 65 65 💬 |
314 | Autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with lentiviral vector that encodes for the human Wiskott Aldrich Syndrome (WAS) cDNA sequence | - | - | - | - | 1件: 65 65 💬 |
315 | Avalglucosidase Alfa | 1件: Avalglucosidase alfa Avalglucosidase alfa | 1件: Avalglucosidase alfa
Avalglucosidase alfa
💬 | 1件: GAA GAA 💬 | 4件: Galactose metabolism Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬 | 1件: 256 256 💬 |
316 | Avalglucosidase alfa (GZ402666) | 1件: Avalglucosidase alfa Avalglucosidase alfa | 1件: Avalglucosidase alfa
Avalglucosidase alfa
💬 | 1件: GAA GAA 💬 | 4件: Galactose metabolism Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬 | 1件: 256 256 💬 |
317 | Avalglucosidase Alfa (NeoGAA) | 1件: Avalglucosidase alfa Avalglucosidase alfa | 1件: Avalglucosidase alfa
Avalglucosidase alfa
💬 | 1件: GAA GAA 💬 | 4件: Galactose metabolism Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬 | 1件: 256 256 💬 |
318 | Avalglucosidase alfa GZ402666 | 1件: Avalglucosidase alfa Avalglucosidase alfa | 1件: Avalglucosidase alfa
Avalglucosidase alfa
💬 | 1件: GAA GAA 💬 | 4件: Galactose metabolism Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬 | 1件: 256 256 💬 |
319 | Avalglucosidase alfa-NGPT (GZ402666) | 1件: Avalglucosidase alfa Avalglucosidase alfa | 1件: Avalglucosidase alfa
Avalglucosidase alfa
💬 | 1件: GAA GAA 💬 | 4件: Galactose metabolism Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬 | 1件: 256 256 💬 |
320 | Avalglucosidase alfa-NGPT (GZ402666) IV | 1件: Avalglucosidase alfa Avalglucosidase alfa | 1件: Avalglucosidase alfa
Avalglucosidase alfa
💬 | 1件: GAA GAA 💬 | 4件: Galactose metabolism Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬 | 1件: 256 256 💬 |
321 | Avalglucosidasi alfa | - | - | - | - | 1件: 256 256 💬 |
322 | AZAFOR - 50 MG COMPRESSE RIVESTITE CON FILM 50 COMPRESSE IN BLISTER PVC/PVDC/AL | - | - | - | - | 1件: 97 97 💬 |
323 | Azathioprine and Allopurinol | 2件: Allopurinol Allopurinol, Azathioprine | 2件: Allopurinol
Allopurinol
,
Azathioprine
💬 | 1件: XDH XDH 💬 | 6件: Caffeine metabolism Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Peroxisome, Purine metabolism 💬 | 1件: 97 97 💬 |
324 | AZD3241 Alternative titration scheme with formulation 1 or 2 | - | - | - | - | 1件: 6 6 💬 |
325 | Baminercept (Baminercept alfa (USAN)) | 1件: Baminercept Baminercept (Baminercept alfa) | 1件: Baminercept
Baminercept
(Baminercept alfa (USAN)) 💬 | 1件: LTB LTB 💬 | 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 4件: 13 13, 46, 53, 97 💬 |
326 | Baminercept alfa | 1件: Baminercept Baminercept (Baminercept alfa) | 1件: Baminercept
Baminercept
(Baminercept alfa (USAN)) 💬 | 1件: LTB LTB 💬 | 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 1件: 46 46 💬 |
327 | Baminercept alfa (BG9924) | 1件: Baminercept Baminercept (Baminercept alfa) | 1件: Baminercept
Baminercept
(Baminercept alfa (USAN)) 💬 | 1件: LTB LTB 💬 | 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 1件: 46 46 💬 |
328 | Benzbromaron AL | - | - | - | - | 1件: 86 86 💬 |
329 | Benzoyl-L-tyrosyl-[1-13C]alanine (Bz-Tyr-Ala) | 1件: Alanine Alanine | 1件: Alanine
Alanine
💬 | - | - | 1件: 298 298 💬 |
330 | Beta carotene from Dunaliella algae | 1件: Beta carotene Beta carotene (all-trans-β-carotene) | 1件: beta Carotene
beta Carotene
💬 | - | - | 1件: 96 96 💬 |
331 | Beta-Alanine | 2件: Alanine Alanine, beta-Alanine | 2件: Alanine
Alanine
,
beta-Alanine
💬 | - | - | 1件: 13 13 💬 |
332 | Beta-alanine supplementation | 2件: Alanine Alanine, beta-Alanine | 2件: Alanine
Alanine
,
beta-Alanine
💬 | - | - | 1件: 13 13 💬 |
333 | Bevacizumab (ALYMSYS) | 1件: Bevacizumab Bevacizumab (Alymsys) | 1件: Bevacizumab
Bevacizumab
(ALYMSYS) 💬 | 1件: VEGFA VEGFA 💬 | 24件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬 | 6件: 13 13, 34, 85, 87, 227, 280 💬 |
334 | Bevacizumab (Avastin) and Imatinib Mesylate (Gleevec) (ALYMSYS) | 2件: Bevacizumab Bevacizumab (Alymsys), Imatinib | 2件: Bevacizumab
Bevacizumab
(ALYMSYS),
Imatinib
💬 | 4件: ABL1 ABL1, KIT, PDGFRA, VEGFA 💬 | 45件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Acute myeloid leukemia, Axon guidance, Bladder cancer, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Glioma, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pancreatic cancer, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway, Viral myocarditis 💬 | 1件: 87 87 💬 |
335 | Bevacizumab (Genitical Recombination) (ALYMSYS) | 1件: Bevacizumab Bevacizumab (Alymsys) | 1件: Bevacizumab
Bevacizumab
(ALYMSYS) 💬 | 1件: VEGFA VEGFA 💬 | 24件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬 | 1件: 34 34 💬 |
336 | BEVACIZUMAB ZIRCONIUM ZR-89 (ALYMSYS) | 2件: Bevacizumab Bevacizumab (Alymsys), Bevacizumab zirconium Zr-89 | 1件: Bevacizumab
Bevacizumab
(ALYMSYS) 💬 | 1件: VEGFA VEGFA 💬 | 24件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬 | 1件: 34 34 💬 |
337 | BGJ398 (also known as BBP-831) | - | - | - | - | 1件: 276 276 💬 |
338 | Biological/Vaccine: Allogeneic HB-adMSCs | 1件: Adipose-Derived Mesenchymal Stem Cells: Autologous or Allogeneic Origins Adipose-Derived Mesenchymal Stem Cells: Autologous or Allogeneic Origins | - | - | - | 1件: 6 6 💬 |
339 | BOTOX 100 UNITES ALLERGAN (PR1) | 1件: Botulinum toxin type A Botulinum toxin type A | 1件: Botulinum toxin type A
Botulinum toxin type A
💬 | 1件: SNAP25 SNAP25 💬 | 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 1件: 2 2 💬 |
340 | Bovine intesastinal alkaline phosphatase (bIAP) | 1件: Alkaline Phosphatase Alkaline Phosphatase | - | - | - | 1件: 46 46 💬 |
341 | Bovine intestinal alkaline phosphatase (BIAP) | 1件: Alkaline Phosphatase Alkaline Phosphatase | - | - | - | 1件: 97 97 💬 |
342 | Bovine-Calf Alkaline Phosphatase (BIAP) | 1件: Alkaline Phosphatase Alkaline Phosphatase | - | - | - | 1件: 97 97 💬 |
343 | Bovine-Calf Alkaline Phosphatase BIAP | 1件: Alkaline Phosphatase Alkaline Phosphatase | - | - | - | 1件: 97 97 💬 |
344 | Brigatinib (Alunbrig (TN)) | 1件: Brigatinib Brigatinib (Alunbrig) | 1件: Brigatinib
Brigatinib
(Alunbrig (TN)) 💬 | 1件: ALK ALK 💬 | 3件: Non-small cell lung cancer Non-small cell lung cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer 💬 | 1件: 34 34 💬 |
345 | Bucelipase alfa | 1件: Bucelipase alfa Bucelipase alfa | - | - | - | 1件: 299 299 💬 |
346 | Bupivicaine alone | - | - | - | - | 1件: 298 298 💬 |
347 | C. albicans | - | - | - | - | 1件: 46 46 💬 |
348 | Caffeine alkaloid | 1件: Caffeine Caffeine (Alert Aid) | 2件: Caffeine
Caffeine
,
Caffeine hydrate
💬 | 11件: ADORA1 ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬 | 22件: Alcoholism Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 💬 |
349 | Calcium carbonate and alphacalcidol | 3件: Calcium Calcium (P D All), Calcium carbonate (Alka-Seltzer Cool Action Extra Strength ReliefChews Mint), Carbonate ion | 2件: Calcium carbonate
Calcium carbonate
,
Calcium carbonate
💬 | - | - | 1件: 235 235 💬 |
350 | Campath, Chemo and/or TBI Allo SCT | 1件: Alemtuzumab Alemtuzumab | 1件: Alemtuzumab
Alemtuzumab
💬 | 1件: CD52 CD52 💬 | - | 3件: 60 60, 62, 283 💬 |
351 | CAMPATH-1H (Alemtuzumab) | 1件: Alemtuzumab Alemtuzumab | 1件: Alemtuzumab
Alemtuzumab
💬 | 1件: CD52 CD52 💬 | - | 1件: 60 60 💬 |
352 | Caplacizumab (ALX-0081) | 1件: Caplacizumab Caplacizumab | 1件: Caplacizumab
Caplacizumab
💬 | 1件: VWF VWF 💬 | 8件: Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬 | 1件: 64 64 💬 |
353 | Caplacizumab (an anti-von Willebrand Factor Nanobody ALX-0081) | 2件: Caplacizumab Caplacizumab, Von Willebrand factor human (Alphanate) | 1件: Caplacizumab
Caplacizumab
💬 | 1件: VWF VWF 💬 | 8件: Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬 | 1件: 64 64 💬 |
354 | Carmustine, etoposide, cytarabine, and melphalan (BEAM) (Alkeran (TN)) | 4件: Carmustine Carmustine, Cytarabine, Etoposide, Melphalan (Alkeran) | 4件: Etoposide
Etoposide
,
Cytarabine
,
Carmustine
,
Melphalan
(Alkeran (TN)) 💬 | 2件: TOP2A TOP2A, TOP2B 💬 | 1件: Platinum drug resistance Platinum drug resistance 💬 | 1件: 13 13 💬 |
355 | CD3/CD19 neg allogeneic BMT | - | - | - | - | 1件: 65 65 💬 |
356 | CD3/CD19 negative allogeneic hematopoietic stem cells | - | - | - | - | 1件: 65 65 💬 |
357 | Cell-based therapy of autologous adipose derived regenerative cells transplanted intraspinally and intrathecally in ALS patients | - | - | - | - | 1件: 2 2 💬 |
358 | Cellule CD34+ autologhe trasdotte con IDUA LV codificante per il cDNA dell'alfa-L-iduronidasi | - | - | - | - | 1件: 19 19 💬 |
359 | Celulas hepatocitos troncales adultas alogenicas de higado expandidas | - | - | - | - | 1件: 251 251 💬 |
360 | Celulas madre mesenquimales troncales adultas alogenicas de médula ósea no expandida | - | - | - | - | 1件: 274 274 💬 |
361 | Cerliponase Alfa | 1件: Cerliponase alfa Cerliponase alfa | 1件: Cerliponase alfa
Cerliponase alfa
💬 | 1件: TPP1 TPP1 💬 | 1件: Lysosome Lysosome 💬 | 1件: 19 19 💬 |
362 | CETIRIZINA SANDOZ - 10 MG COMPRESSE RIVESTITE CON FILM 20 COMPRESSE IN BLISTER PVC/ALU | 1件: Cetirizine Cetirizine (all day allergy-D) | 1件: Cetirizine
Cetirizine
💬 | 1件: HRH1 HRH1 💬 | 3件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | 1件: 300 300 💬 |
363 | Ciclesonide (Alvesco (TN)) | 1件: Ciclesonide Ciclesonide (Alvesco) | 1件: Ciclesonide
Ciclesonide
(Alvesco (TN)) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 84 84 💬 |
364 | CIMZIA - 200MG-SOLUZIONE INIETTABILE-USO SOTTOCUTANEO-SIRINGA PRERIEMPITA(VETRO) 1ML 6(3X2) SIRINGHE PRERIEMPITE+6(3X2) SALVIETTINE IMBEVUTE DI ALCOOL | 1件: Certolizumab pegol Certolizumab pegol | 1件: Certolizumab pegol
Certolizumab pegol
💬 | 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬 |
365 | Cipaglucosidase Alfa | 1件: Cipaglucosidase alfa Cipaglucosidase alfa | 1件: Cipaglucosidase alfa
Cipaglucosidase alfa
💬 | 1件: GAA GAA 💬 | 4件: Galactose metabolism Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬 | 1件: 256 256 💬 |
366 | Cipaglucosidasi alfa | - | - | - | - | 1件: 256 256 💬 |
367 | Clobetasol propionate alone | 2件: Clobetasol Clobetasol, Clobetasol propionate | 2件: Clobetasol propionate
Clobetasol propionate
,
Clobetasol
💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 162 162 💬 |
368 | Combination of Minocycline and MTX or MTX alone | 1件: Minocycline Minocycline | 1件: Minocycline
Minocycline
💬 | - | - | 1件: 46 46 💬 |
369 | Combination Oral Budesonide and Rectal Hydrocortisone (ALKINDI) | 2件: Budesonide Budesonide (Childrens RHINOCORT Allergy), Hydrocortisone (Meijer Anti-itch with Aloe) | 2件: Hydrocortisone
Hydrocortisone
(ALKINDI),
Budesonide
💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 💬 |
370 | Conventional Glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone) (ALKINDI) | 7件: Acetate Acetate, Cortisone, Cortisone acetate, Dexamethasone, Hydrocortisone (Meijer Anti-itch with Aloe), Prednisolone, Prednisone (Contrast Allergy PreMed Pack) | 6件: Hydrocortisone
Hydrocortisone
(ALKINDI),
Dexamethasone
,
Prednisolone
,
Prednisone
,
Cortisone acetate
,
Cortisone
💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 💬 |
371 | Cortef (hydrocortisone) (ALKINDI) | 1件: Hydrocortisone Hydrocortisone (Meijer Anti-itch with Aloe) | 1件: Hydrocortisone
Hydrocortisone
(ALKINDI) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 83 83 💬 |
372 | Crema de rapamicina al 1% y excipientes | - | - | - | - | 1件: 157 157 💬 |
373 | CS20AT04 (allogenic bone marrow derived mesenchymal stem cell) | - | - | - | - | 1件: 49 49 💬 |
374 | CSM allogéniques issues de cordons ombilicaux ( MTI-PP) | - | - | - | - | 1件: 49 49 💬 |
375 | Cultured allogeneic fibroblasts | - | - | - | - | 1件: 36 36 💬 |
376 | Current treatment of AL-CM | - | - | - | - | 1件: 28 28 💬 |
377 | CYCLO[L-ALANYL-L-SERYL-L-ISOLEUCYL-L-PROLYL-L-PROLYL-L-GLUTAMINYL-L-LYSYL-L-TYROSYL-D-PROLYL-L-PROLYL-(2S)-2-AMINODECANOYL-L-ALPHA-GLUTAMYL-L-THREONYL] | - | - | - | - | 1件: 299 299 💬 |
378 | Cytoreductive regimen followed by a CD34+E- selected allogeneic stem cell transplant | - | - | - | - | 1件: 62 62 💬 |
379 | Células mesenquimales troncales adultas alogénicas de médula ósea no expandidas | - | - | - | - | 1件: 274 274 💬 |
380 | Células mesenquimales troncales adultas alogénicas de médula ósea no expandidas(ref cruzada PEI nº 12-088) | - | - | - | - | 1件: 274 274 💬 |
381 | D-Galactose (alpha-D-Galactose) | 1件: Galactose Galactose | 1件: Galactose
Galactose
(alpha-D-Galactose) 💬 | - | - | 1件: 222 222 💬 |
382 | Danicopan (ALXN2040) | 1件: Danicopan Danicopan | 1件: Danicopan
Danicopan
💬 | 1件: CFD CFD 💬 | 3件: Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection 💬 | 1件: 62 62 💬 |
383 | Daratumumab co-formulated with recombinant human hyaluronidase (rHuPH20) (Vorhyaluronidase alfa (genetical recombination) (JAN)) | 3件: Daratumumab Daratumumab, Hyaluronidase, Hyaluronidase (human recombinant) (Vorhyaluronidase alfa) | 4件: Hyaluronidase
Hyaluronidase
,
Hyaluronidase
,
Hyaluronidase
(Vorhyaluronidase alfa (genetical recombination) (JAN)),
Daratumumab
💬 | 1件: CD38 CD38 💬 | 7件: Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | 1件: 28 28 💬 |
384 | DARVADSTROCEL (Alofisel (TN)) | 1件: Darvadstrocel Darvadstrocel (Alofisel) | 1件: Darvadstrocel
Darvadstrocel
(Alofisel (TN)) 💬 | - | - | 1件: 96 96 💬 |
385 | Davunetide (AL-108, NAP) | 1件: Davunetide Davunetide | 1件: Davunetide
Davunetide
💬 | - | - | 3件: 5 5, 7, 127 💬 |
386 | Dehydrated Alcohol (Absolute Alcohol) BP for Injection | 1件: Ethanol Ethanol (Integrity Made LLC Aloe Scent with Vitamin E HANDSANITIZER) | 1件: Ethanol
Ethanol
💬 | - | - | 1件: 279 279 💬 |
387 | Desert Harvest Aloe Vera Capsules | 1件: Aloe vera leaf Aloe vera leaf | - | - | - | 1件: 226 226 💬 |
388 | Dimebon alone | 1件: Latrepirdine Latrepirdine | 1件: Latrepirdine
Latrepirdine
💬 | 6件: ACHE ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 22件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 8 8 💬 |
389 | Donepezil (Allydone (TN)) | 1件: Donepezil Donepezil | 1件: Donepezil
Donepezil
(Allydone (TN)) 💬 | 1件: ACHE ACHE 💬 | 2件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | 9件: 5 5, 6, 13, 46, 78, 124, 127, 156, 206 💬 |
390 | Donepezil HCI (drug) (Allydone (TN)) | 1件: Donepezil Donepezil | 1件: Donepezil
Donepezil
(Allydone (TN)) 💬 | 1件: ACHE ACHE 💬 | 2件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | 1件: 13 13 💬 |
391 | Donepezil hydrochloride (Allydone (TN)) | 1件: Donepezil Donepezil | 1件: Donepezil
Donepezil
(Allydone (TN)) 💬 | 1件: ACHE ACHE 💬 | 2件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | 3件: 6 6, 124, 156 💬 |
392 | Donepezil Sandoz (Allydone (TN)) | 1件: Donepezil Donepezil | 1件: Donepezil
Donepezil
(Allydone (TN)) 💬 | 1件: ACHE ACHE 💬 | 2件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | 1件: 6 6 💬 |
393 | Dornase alfa | 1件: Dornase alfa Dornase alfa | 1件: Dornase alfa
Dornase alfa
💬 | - | - | 2件: 53 53, 299 💬 |
394 | Dornase alfa (Pulmozyme) | 1件: Dornase alfa Dornase alfa | 1件: Dornase alfa
Dornase alfa
💬 | - | - | 1件: 299 299 💬 |
395 | Dornase alfa [Pulmozyme®] | 1件: Dornase alfa Dornase alfa | 1件: Dornase alfa
Dornase alfa
💬 | - | - | 1件: 299 299 💬 |
396 | Dornase alpha | 1件: Dornase alfa Dornase alfa | 1件: Dornase alfa
Dornase alfa
💬 | - | - | 1件: 299 299 💬 |
397 | Dose of 60 mg/kg alpha1-proteinase inhibitor | 1件: Alpha-1-proteinase inhibitor Alpha-1-proteinase inhibitor | - | - | - | 1件: 231 231 💬 |
398 | Dose of 60 mg/kg Fraction IV-1 Alpha1-Proteinase Inhibitor | 1件: Alpha-1-proteinase inhibitor Alpha-1-proteinase inhibitor | - | - | - | 1件: 231 231 💬 |
399 | Dual release hydrocortisone (plenadren) (ALKINDI) | 1件: Hydrocortisone Hydrocortisone (Meijer Anti-itch with Aloe) | 1件: Hydrocortisone
Hydrocortisone
(ALKINDI) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 💬 |
400 | Efanesoctocog alfa | 1件: Efanesoctocog alfa Efanesoctocog alfa | 1件: Efanesoctocog alfa
Efanesoctocog alfa
💬 | - | - | 1件: 288 288 💬 |
401 | EFAVALEUKIN ALFA | 1件: Efavaleukin alfa Efavaleukin alfa | 1件: Efavaleukin alfa
Efavaleukin alfa
💬 | - | - | 2件: 49 49, 97 💬 |
402 | EFGARTIGIMOD ALFA | 1件: Efgartigimod alfa Efgartigimod alfa | 1件: Efgartigimod alfa
Efgartigimod alfa
💬 | 1件: FCGRT FCGRT 💬 | - | 6件: 11 11, 14, 35, 53, 63, 162 💬 |
403 | Efgartigimod alpha | - | - | - | - | 1件: 63 63 💬 |
404 | Efmarodocokin alfa | 1件: Efmarodocokin alfa Efmarodocokin alfa | 1件: Efmarodocokin alfa
Efmarodocokin alfa
💬 | 1件: IL22 IL22 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Th17 cell differentiation 💬 | 2件: 96 96, 97 💬 |
405 | Egg Albumen Powder | 2件: Egg Egg, Egg white (Egg white allergenic extract) | - | - | - | 1件: 96 96 💬 |
406 | Elosulfase alfa | 1件: Elosulfase alfa Elosulfase alfa | 1件: Elosulfase alfa
Elosulfase alfa
💬 | 1件: GALNS GALNS 💬 | 3件: Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | 1件: 19 19 💬 |
407 | Elosulfase Alfa 1 MG/ML Intravenous Solution [VIMIZIM] | 1件: Elosulfase alfa Elosulfase alfa | 1件: Elosulfase alfa
Elosulfase alfa
💬 | 1件: GALNS GALNS 💬 | 3件: Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | 1件: 19 19 💬 |
408 | ENBREL - 50 MG SOLUZIONE INIETTABILE IN SIRINGA (VETRO DA 1 ML) PRERIEMPITA - USO SOTTOCUTANEO 12 SIRINGHE PRERIEMPITE + 24 TAMPONI IMBEVUTI DI ALCOL | 1件: Etanercept Etanercept | 1件: Etanercept
Etanercept
💬 | 2件: LTA LTA, TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬 |
409 | EnteraBio's Oral Parathyroid Hormone (1-34) (ALX 1-11) | 1件: Parathyroid hormone Parathyroid hormone | 1件: Parathyroid hormone
Parathyroid hormone
(ALX 1-11) 💬 | 2件: PTH1R PTH1R, PTH2R 💬 | 3件: Endocrine and other factor-regulated calcium reabsorption Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬 | 1件: 235 235 💬 |
410 | Enzyme replacement therapy (Agalsidase alpha (Replagal®)) | 1件: Agalsidase alfa Agalsidase alfa | 1件: Agalsidase alfa
Agalsidase alfa
💬 | 1件: GLA GLA 💬 | 6件: Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬 | 1件: 19 19 💬 |
411 | Epoetin alfa | 1件: Erythropoietin Erythropoietin (Epoetin alfa-epbx) | - | - | - | 3件: 13 13, 18, 46 💬 |
412 | ERA and PDE-5I (Sildenafil, Tadalafil, Bosentan, Macitentan) (ALYQ) | 4件: Bosentan Bosentan (Alembic-bosentan), Macitentan, Sildenafil, Tadalafil (Alyq) | 5件: Bosentan
Bosentan
,
Tadalafil
(ALYQ),
Bosentan
,
Sildenafil
,
Macitentan
💬 | 3件: EDNRA EDNRA, EDNRB, PDE5A 💬 | 11件: Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬 |
413 | ETN Alone | - | - | - | - | 1件: 46 46 💬 |
414 | Expanded allogenic adipose-derived adult stem cells | - | - | - | - | 1件: 96 96 💬 |
415 | Expanded human allogenic mesemchymal adult stem cells extracted from adipose tissue (eASCs) | - | - | - | - | 1件: 96 96 💬 |
416 | Expanded human allogenic mesenchymal adult stem cells extractd from adipose tissue (eASCs) | - | - | - | - | 1件: 96 96 💬 |
417 | Expanded human allogenic mesenchymal adult stem cells extracted from adipose | - | - | - | - | 1件: 96 96 💬 |
418 | Expanded human allogenic mesenchymal adult stem cells extracted from adipose tissue | - | - | - | - | 1件: 96 96 💬 |
419 | Expanded human allogenic mesenchymal adult stem cells extracted from adipose tissue (eASCs | - | - | - | - | 1件: 96 96 💬 |
420 | Expanded human allogenic mesenchymal adult stem cells extracted from adipose tissue (eASCs) | - | - | - | - | 1件: 96 96 💬 |
421 | FDC macitentan/tadalafil (ALYQ) | 2件: Macitentan Macitentan, Tadalafil (Alyq) | 2件: Tadalafil
Tadalafil
(ALYQ),
Macitentan
💬 | 3件: EDNRA EDNRA, EDNRB, PDE5A 💬 | 11件: Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬 |
422 | Filgrastim, Alemtuzumab | 2件: Alemtuzumab Alemtuzumab, Filgrastim | 2件: Alemtuzumab
Alemtuzumab
,
Filgrastim
💬 | 2件: CD52 CD52, CSF3R 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 1件: 65 65 💬 |
423 | FIRDAPSE - 10 MG - COMPRESSE - USO ORALE - BLISTER(ALU/PVC/PVDC) 100 X 1 COMPRESSE | 1件: Amifampridine Amifampridine | 1件: Amifampridine
Amifampridine
💬 | 4件: KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 2件: 3 3, 11 💬 |
424 | Fludarabine, Melphalan, Thiotepa (Alkeran (TN)) | 3件: Fludarabine Fludarabine, Melphalan (Alkeran), Thiotepa | 3件: Melphalan
Melphalan
(Alkeran (TN)),
Thiotepa
,
Fludarabine
💬 | 1件: RRM1 RRM1 💬 | 6件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 65 65 💬 |
425 | Fludarabine/ melphalan (Alkeran (TN)) | 2件: Fludarabine Fludarabine, Melphalan (Alkeran) | 2件: Melphalan
Melphalan
(Alkeran (TN)),
Fludarabine
💬 | 1件: RRM1 RRM1 💬 | 6件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 60 60 💬 |
426 | GA-GCB (velaglucerase alfa) | 1件: Velaglucerase alfa Velaglucerase alfa | 1件: Velaglucerase alfa
Velaglucerase alfa
💬 | 1件: GBA1 GBA1 💬 | 4件: Lysosome Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬 | 1件: 19 19 💬 |
427 | Galactose (alpha-D-Galactose) | 1件: Galactose Galactose | 1件: Galactose
Galactose
(alpha-D-Galactose) 💬 | - | - | 1件: 222 222 💬 |
428 | Gamma-Tocopherol (dl-alpha-Tocopherol) | 2件: Tocopherol Tocopherol (Aloe Vera Sprayer), gamma-Tocopherol | 1件: Tocopherol
Tocopherol
(dl-alpha-Tocopherol) 💬 | - | - | 1件: 13 13 💬 |
429 | Gene activated human glucocerebrosidase, velaglucerase alfa | 1件: Velaglucerase alfa Velaglucerase alfa | 1件: Velaglucerase alfa
Velaglucerase alfa
💬 | 1件: GBA1 GBA1 💬 | 4件: Lysosome Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬 | 1件: 19 19 💬 |
430 | GILENYA - 0.5 MG - CAPSULE RIGIDE - USO ORALE - BLISTER DIVISIBILE PER DOSE UNITARIA(PVC/PVDC/ALU) SCATOLA DA 7X1 CAPSULE | 1件: Fingolimod Fingolimod | 1件: Fingolimod
Fingolimod
💬 | 1件: S1PR1 S1PR1 💬 | 3件: FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 💬 |
431 | GILENYA - 0.5 MG - CAPSULE RIGIDE - USO ORALE - BLISTER(PVC/PVDC/ALU) SCATOLA DA 28 CAPSULE | 1件: Fingolimod Fingolimod | 1件: Fingolimod
Fingolimod
💬 | 1件: S1PR1 S1PR1 💬 | 3件: FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 💬 |
432 | Givosiran (ALN-AS1) | 1件: Givosiran Givosiran | 1件: Givosiran
Givosiran
💬 | 1件: ALAS1 ALAS1 💬 | 4件: Biosynthesis of cofactors Biosynthesis of cofactors, Glycine, serine and threonine metabolism, Metabolic pathways, Porphyrin metabolism 💬 | 1件: 254 254 💬 |
433 | Glucosidase alfa | - | - | - | - | 1件: 256 256 💬 |
434 | Guna-Antiinterleukin 1 alfa | - | - | - | - | 1件: 46 46 💬 |
435 | Heparin & Alkalinized Lidocaine Bladder Instillation | 2件: Heparin Heparin, Lidocaine (Alocane Emergency Burn Pads) | 3件: Lidocaine
Lidocaine
,
Adomiparin
,
Lidocaine hydrochloride monohydrate
💬 | 6件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SERPINC1 💬 | 4件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Complement and coagulation cascades, Dopaminergic synapse, Taste transduction 💬 | 1件: 226 226 💬 |
436 | HLA-identical allogeneic mesoangioblasts | - | - | - | - | 1件: 113 113 💬 |
437 | Human albumin | 1件: Albumin human Albumin human | 1件: Albumin human
Albumin human
💬 | - | - | 2件: 2 2, 96 💬 |
438 | HUMAN ALBUMIN AS MACROAGGREGATES | 1件: Albumin human Albumin human | 1件: Albumin human
Albumin human
💬 | - | - | 1件: 96 96 💬 |
439 | HUMAN ALBUMIN SOLUTION | 1件: Albumin human Albumin human | 1件: Albumin human
Albumin human
💬 | - | - | 1件: 2 2 💬 |
440 | Human allogeneic adipose tissue-derived mesenchymal stem cells expanded | - | - | - | - | 1件: 36 36 💬 |
441 | Human Allogeneic WJ-MSCs | 1件: Human Umbilical Cord Mesenchymal Stem Cells Human Umbilical Cord Mesenchymal Stem Cells | - | - | - | 1件: 36 36 💬 |
442 | Human anti TNF-alpha monoclonal | - | - | - | - | 1件: 46 46 💬 |
443 | Human anti TNF-alpha monoclonal antibody | - | - | - | - | 2件: 46 46, 84 💬 |
444 | Human anti-TNF-alpha monoclonal antibody | - | - | - | - | 3件: 46 46, 97, 107 💬 |
445 | Human IgG1 monoclonal antibody against alpha-synuclein | - | - | - | - | 1件: 17 17 💬 |
446 | HUMAN LEUCOCYTE INTERFERON-ALPHA | - | - | - | - | 1件: 13 13 💬 |
447 | Human recombinant parathyroid Hormone (ALX 1-11) | 1件: Parathyroid hormone Parathyroid hormone | 1件: Parathyroid hormone
Parathyroid hormone
(ALX 1-11) 💬 | 2件: PTH1R PTH1R, PTH2R 💬 | 3件: Endocrine and other factor-regulated calcium reabsorption Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬 | 1件: 235 235 💬 |
448 | Human Recombinant Tissue Non-Specific Alkaline Phosphatase Fusion Protein | 1件: Alkaline Phosphatase Alkaline Phosphatase | - | - | - | 1件: 172 172 💬 |
449 | Human serum albumin | 1件: Albumin human Albumin human | 1件: Albumin human
Albumin human
💬 | - | - | 1件: 78 78 💬 |
450 | HUMAN SERUM ALBUMIN (HSA) FUSED TO RECOMBINANT HUMAN GROWTH HORMONE (HGH) | 2件: Albumin human Albumin human, Somatotropin | 1件: Albumin human
Albumin human
💬 | - | - | 1件: 78 78 💬 |
451 | Human Serum Albumin (HSA) fused to somatropin | 2件: Albumin human Albumin human, Somatotropin | 1件: Albumin human
Albumin human
💬 | - | - | 1件: 78 78 💬 |
452 | Humanized anti-alpha v beta 6 mAb | - | - | - | - | 1件: 85 85 💬 |
453 | Humanized IgG1, kappa anti-serum amyloid A and anti-AL amyloid antibody | - | - | - | - | 1件: 28 28 💬 |
454 | HUMIRA - 40 MG SOLUZIONE INIETTABILE USO SOTTOCUTANEO 1 SIRINGA PRERIEMPITA 0.8 ML + 1 TAMPONE IMBEVUTO DI ALCOL IN UN BLISTER | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬 | 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 56 56, 97 💬 |
455 | HUMIRA - 40 MG SOLUZIONE INIETTABILE USO SOTTOCUTANEO 2 SIRINGHE PRERIEMPITE 0.8 ML + 2 TAMPONI IMBEVUTI DI ALCOL IN 1 BLISTER | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬 | 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬 |
456 | HUMIRA - 40MG/0.8ML SOLUZ. INIETTABILE- USO SOTTOCUTANEO-FLACONCINO(VETRO) 0.8ML 2 ASTUCCI:1 FLACONCINO+1SIRINGA+1AGO+1ADATT.STERILE-2TAMPONI IMBEVUTI ALCOOL | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬 | 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 46 46, 96 💬 |
457 | Hyaluronidase (Vorhyaluronidase alfa (genetical recombination) (JAN)) | 2件: Hyaluronidase Hyaluronidase, Hyaluronidase (human recombinant) (Vorhyaluronidase alfa) | 3件: Hyaluronidase
Hyaluronidase
,
Hyaluronidase
,
Hyaluronidase
(Vorhyaluronidase alfa (genetical recombination) (JAN)) 💬 | - | - | 5件: 14 14, 28, 51, 65, 331 💬 |
458 | Hyaluronidase injected intradermally (Vorhyaluronidase alfa (genetical recombination) (JAN)) | 1件: Hyaluronidase Hyaluronidase | 3件: Hyaluronidase
Hyaluronidase
,
Hyaluronidase
,
Hyaluronidase
(Vorhyaluronidase alfa (genetical recombination) (JAN)) 💬 | - | - | 1件: 51 51 💬 |
459 | Hydrocortisone (ALKINDI) | 2件: Hydrocortisone Hydrocortisone (Meijer Anti-itch with Aloe), Hydrocortisone acetate (Alumier MD Post Procedure Kit with Hydrocortisone) | 2件: Hydrocortisone
Hydrocortisone
(ALKINDI),
Hydrocortisone acetate
💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 10件: 6 6, 41, 46, 53, 75, 78, 81, 83, 97, 299 💬 |
460 | Hydrocortisone (Solucortef) (ALKINDI) | 1件: Hydrocortisone Hydrocortisone (Meijer Anti-itch with Aloe) | 1件: Hydrocortisone
Hydrocortisone
(ALKINDI) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 💬 |
461 | Hydrocortisone 100mg/ml (ALKINDI) | 1件: Hydrocortisone Hydrocortisone (Meijer Anti-itch with Aloe) | 1件: Hydrocortisone
Hydrocortisone
(ALKINDI) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 83 83 💬 |
462 | Hydrocortisone 10mg (ALKINDI) | 1件: Hydrocortisone Hydrocortisone (Meijer Anti-itch with Aloe) | 1件: Hydrocortisone
Hydrocortisone
(ALKINDI) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 💬 |
463 | Hydrocortisone 10mg Tablet (ALKINDI) | 1件: Hydrocortisone Hydrocortisone (Meijer Anti-itch with Aloe) | 1件: Hydrocortisone
Hydrocortisone
(ALKINDI) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 💬 |
464 | Hydrocortisone 10mg Tablets (ALKINDI) | 1件: Hydrocortisone Hydrocortisone (Meijer Anti-itch with Aloe) | 1件: Hydrocortisone
Hydrocortisone
(ALKINDI) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 💬 |
465 | Hydrocortisone 20mg Tablets (ALKINDI) | 1件: Hydrocortisone Hydrocortisone (Meijer Anti-itch with Aloe) | 1件: Hydrocortisone
Hydrocortisone
(ALKINDI) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 💬 |
466 | HYDROCORTISONE ACETATE (ALKINDI) | 3件: Acetate Acetate, Hydrocortisone (Meijer Anti-itch with Aloe), Hydrocortisone acetate (Alumier MD Post Procedure Kit with Hydrocortisone) | 2件: Hydrocortisone
Hydrocortisone
(ALKINDI),
Hydrocortisone acetate
💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 💬 |
467 | Hydrocortisone cream (ALKINDI) | 1件: Hydrocortisone Hydrocortisone (Meijer Anti-itch with Aloe) | 1件: Hydrocortisone
Hydrocortisone
(ALKINDI) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 6 6 💬 |
468 | Hydrocortisone cream 1% (ALKINDI) | 1件: Hydrocortisone Hydrocortisone (Meijer Anti-itch with Aloe) | 1件: Hydrocortisone
Hydrocortisone
(ALKINDI) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 6 6 💬 |
469 | Hydrocortisone cream 10mg/g FNA Fagron (ALKINDI) | 1件: Hydrocortisone Hydrocortisone (Meijer Anti-itch with Aloe) | 1件: Hydrocortisone
Hydrocortisone
(ALKINDI) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 6 6 💬 |
470 | HYDROCORTISONE HYDROGEN SUCCINATE (ALKINDI) | 3件: Hydrocortisone Hydrocortisone (Meijer Anti-itch with Aloe), Hydrocortisone succinate, Hydrogen | 2件: Hydrocortisone
Hydrocortisone
(ALKINDI),
Hydrocortisone succinate
💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 83 83 💬 |
471 | HYDROCORTISONE MICRONIZED (ALKINDI) | 1件: Hydrocortisone Hydrocortisone (Meijer Anti-itch with Aloe) | 1件: Hydrocortisone
Hydrocortisone
(ALKINDI) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 💬 |
472 | Hydrocortisone Modified Release Capsules (ALKINDI) | 1件: Hydrocortisone Hydrocortisone (Meijer Anti-itch with Aloe) | 1件: Hydrocortisone
Hydrocortisone
(ALKINDI) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 💬 |
473 | HYDROCORTISONE ROUSSEL (ALKINDI) | 1件: Hydrocortisone Hydrocortisone (Meijer Anti-itch with Aloe) | 1件: Hydrocortisone
Hydrocortisone
(ALKINDI) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 83 83 💬 |
474 | Hydrocortisone sodium acetate (ALKINDI) | 3件: Acetate Acetate, Hydrocortisone (Meijer Anti-itch with Aloe), Sodium acetate | 2件: Hydrocortisone
Hydrocortisone
(ALKINDI),
Sodium acetate
💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 💬 |
475 | HYDROCORTISONE SODIUM PHOSPHATE (ALKINDI) | 2件: Hydrocortisone Hydrocortisone (Meijer Anti-itch with Aloe), Phosphate ion | 1件: Hydrocortisone
Hydrocortisone
(ALKINDI) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 3件: 53 53, 81, 83 💬 |
476 | HYDROCORTISONE SODIUM SUCCINATE (ALKINDI) | 1件: Hydrocortisone Hydrocortisone (Meijer Anti-itch with Aloe) | 1件: Hydrocortisone
Hydrocortisone
(ALKINDI) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 3件: 81 81, 83, 97 💬 |
477 | Hydrocortisone tablet 2.5 mg (ALKINDI) | 1件: Hydrocortisone Hydrocortisone (Meijer Anti-itch with Aloe) | 1件: Hydrocortisone
Hydrocortisone
(ALKINDI) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 💬 |
478 | Hydrocortisone TAKEDA, tabletter (ALKINDI) | 1件: Hydrocortisone Hydrocortisone (Meijer Anti-itch with Aloe) | 1件: Hydrocortisone
Hydrocortisone
(ALKINDI) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 78 78 💬 |
479 | HYDROCORTISONE- hydrocortisone tablet (ALKINDI) | 1件: Hydrocortisone Hydrocortisone (Meijer Anti-itch with Aloe) | 1件: Hydrocortisone
Hydrocortisone
(ALKINDI) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 💬 |
480 | Hydroxocobalamin (AlphaRedisol (TN)) | 1件: Hydroxocobalamin Hydroxocobalamin | 1件: Hydroxocobalamin
Hydroxocobalamin
(AlphaRedisol (TN)) 💬 | - | - | 1件: 97 97 💬 |
481 | Hydroxocobalamin with Butyrate (AlphaRedisol (TN)) | 2件: Butyric Acid Butyric Acid, Hydroxocobalamin | 1件: Hydroxocobalamin
Hydroxocobalamin
(AlphaRedisol (TN)) 💬 | - | - | 1件: 97 97 💬 |
482 | HYNR-CS-Allo | - | - | - | - | 1件: 2 2 💬 |
483 | HYNRCS-Allo inj | - | - | - | - | 1件: 2 2 💬 |
484 | Ibandronate+alfacalcidol+calcium | 3件: Alfacalcidol Alfacalcidol, Calcium (P D All), Ibandronate | 1件: Alfacalcidol
Alfacalcidol
💬 | 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 49 49 💬 |
485 | Imiquimod (Aldara (TN)) | 1件: Imiquimod Imiquimod (Aldara) | 1件: Imiquimod
Imiquimod
(Aldara (TN)) 💬 | 1件: TLR7 TLR7 💬 | 5件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Influenza A, Measles, Neutrophil extracellular trap formation, Toll-like receptor signaling pathway 💬 | 2件: 34 34, 51 💬 |
486 | Imiquimod 5% Cream (Aldara (TN)) | 1件: Imiquimod Imiquimod (Aldara) | 1件: Imiquimod
Imiquimod
(Aldara (TN)) 💬 | 1件: TLR7 TLR7 💬 | 5件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Influenza A, Measles, Neutrophil extracellular trap formation, Toll-like receptor signaling pathway 💬 | 2件: 34 34, 51 💬 |
487 | Immediate post operative bioassay of Parathyroid Hormone (ALX 1-11) | 1件: Parathyroid hormone Parathyroid hormone | 1件: Parathyroid hormone
Parathyroid hormone
(ALX 1-11) 💬 | 2件: PTH1R PTH1R, PTH2R 💬 | 3件: Endocrine and other factor-regulated calcium reabsorption Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬 | 1件: 235 235 💬 |
488 | INALOSSIN - 800 PPM MOL/MOL GAS MEDICINALE COMPRESSO BOMBOLA IN ALLUMINIO CON VALVOLA VI DA 20 LITRI | - | - | - | - | 1件: 294 294 💬 |
489 | Infliximab (IFX alone) | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬 | 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 💬 |
490 | Infusion without ALD518' | - | - | - | - | 1件: 46 46 💬 |
491 | INJECTION OF ALLOGENEIC MESENCHYMAL STEM CELLS | - | - | - | - | 1件: 51 51 💬 |
492 | INN Parathyroid Hormone (1-84) human (ALX 1-11) | 1件: Parathyroid hormone Parathyroid hormone | 1件: Parathyroid hormone
Parathyroid hormone
(ALX 1-11) 💬 | 2件: PTH1R PTH1R, PTH2R 💬 | 3件: Endocrine and other factor-regulated calcium reabsorption Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬 | 1件: 235 235 💬 |
493 | Interferon alfa | 1件: Interferon alfa Interferon alfa | 1件: Interferon alfa
Interferon alfa
💬 | 2件: IFNAR1 IFNAR1, IFNAR2 💬 | 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 5件: 25 25, 26, 28, 56, 96 💬 |
494 | Interferon Alfa-2A | 2件: Interferon alfa Interferon alfa, Interferon alfa-2a | 2件: Interferon alfa-2a
Interferon alfa-2a
,
Interferon alfa
💬 | 2件: IFNAR1 IFNAR1, IFNAR2 💬 | 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 56 56 💬 |
495 | Interferon alfa-2b | 2件: Interferon alfa Interferon alfa, Interferon alfa-2b | 2件: Interferon alfa-2b
Interferon alfa-2b
,
Interferon alfa
💬 | 2件: IFNAR1 IFNAR1, IFNAR2 💬 | 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 25 25 💬 |
496 | Interferon alpha oral lozenge | - | - | - | - | 1件: 85 85 💬 |
497 | Interferon alpha-2a | 1件: Interferon alfa-2a Interferon alfa-2a | 1件: Interferon alfa-2a
Interferon alfa-2a
💬 | 2件: IFNAR1 IFNAR1, IFNAR2 💬 | 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 56 56 💬 |
498 | Interferon alpha-2B | 1件: Interferon alfa-2b Interferon alfa-2b | 1件: Interferon alfa-2b
Interferon alfa-2b
💬 | 2件: IFNAR1 IFNAR1, IFNAR2 💬 | 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 34 34 💬 |
499 | Interferon beta-1a (Rebif®) alone | 2件: Human interferon beta Human interferon beta, Interferon beta-1a | 1件: Interferon beta-1a
Interferon beta-1a
💬 | 2件: IFNAR1 IFNAR1, IFNAR2 💬 | 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬 |
500 | Interferon-alpha | - | - | - | - | 1件: 331 331 💬 |
501 | Interferon-alpha lozenges | - | - | - | - | 1件: 85 85 💬 |
502 | Interferon-alpha2a | - | - | - | - | 1件: 56 56 💬 |
503 | Interferons, glatiramer acetate, teriflunomide, dimethyl fumarate, alemtuzumab, cladribine, fingolimod, ponesimod, rituximab, ocrelizumab, ofatumumab, natalizumab | 12件: Acetate Acetate, Alemtuzumab, Cladribine, Dimethyl fumarate, Fingolimod, Glatiramer, Natalizumab (Anti-alpha4 integrin), Ocrelizumab, Ofatumumab, Ponesimod, Rituximab, Teriflunomide | 10件: Cladribine
Cladribine
,
Alemtuzumab
,
Rituximab
,
Dimethyl fumarate
,
Ocrelizumab
,
Natalizumab
,
Ofatumumab
,
Fingolimod
,
Teriflunomide
,
Ponesimod
💬 | 7件: CD52 CD52, DHODH, ITGA4, KEAP1, MS4A1, RRM1, S1PR1 💬 | 30件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Biosynthesis of cofactors, Cell adhesion molecules, Chemical carcinogenesis - reactive oxygen species, Dilated cardiomyopathy, Drug metabolism - other enzymes, ECM-receptor interaction, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Glutathione metabolism, Hematopoietic cell lineage, Hepatocellular carcinoma, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, Metabolic pathways, Neuroactive ligand-receptor interaction, Nucleotide metabolism, PI3K-Akt signaling pathway, Parkinson disease, Pathways in cancer, Purine metabolism, Pyrimidine metabolism, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, Ubiquitin mediated proteolysis, Yersinia infection 💬 | 1件: 13 13 💬 |
504 | Interleukin-2 (aldesleukin). | 2件: Aldesleukin Aldesleukin, Human interleukin-2 | 1件: Aldesleukin
Aldesleukin
💬 | 3件: IL2RA IL2RA, IL2RB, IL2RG 💬 | 14件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬 | 2件: 96 96, 97 💬 |
505 | Intrathecal recombinant human alpha iduronidase | - | - | - | - | 1件: 19 19 💬 |
506 | IRT Laronidase (Aldurazyme (TN)) | 1件: Laronidase Laronidase (alpha-L-Idosiduronase) | 1件: Laronidase
Laronidase
(Aldurazyme (TN)) 💬 | 1件: IDUA IDUA 💬 | 3件: Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | 1件: 19 19 💬 |
507 | JINARC - 15 MG +45 MG - COMPRESSA - USO ORALE - BLISTER(ALU/PVC) IN CONFEZIONE A PORTAFOGLIO - 56 COMPRESSE (28X15 MG + 28 X 45 MG) | 1件: Tolvaptan Tolvaptan | 1件: Tolvaptan
Tolvaptan
💬 | 1件: AVPR2 AVPR2 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 1件: 67 67 💬 |
508 | JINARC - 15 MG - COMPRESSA - USO ORALE - BLISTER (ALU/PVC) - 28 COMPRESSE | 1件: Tolvaptan Tolvaptan | 1件: Tolvaptan
Tolvaptan
💬 | 1件: AVPR2 AVPR2 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 1件: 67 67 💬 |
509 | JINARC - 30 MG + 60 MG - COMPRESSA - USO ORALE - BLISTER(ALU/PVC) IN CONFEZIONE A PORTAFOGLIO - 56 COMPRESSE (28 X 30 MG + 28 X 60 MG) | 1件: Tolvaptan Tolvaptan | 1件: Tolvaptan
Tolvaptan
💬 | 1件: AVPR2 AVPR2 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 1件: 67 67 💬 |
510 | JINARC - 30 MG +90 MG - COMPRESSA - USO ORALE - BLISTER(ALU/PVC) IN CONFEZIONE A PORTAFOGLIO - 56 COMPRESSE (28 X 30 MG + 28 X 90 MG) | 1件: Tolvaptan Tolvaptan | 1件: Tolvaptan
Tolvaptan
💬 | 1件: AVPR2 AVPR2 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 1件: 67 67 💬 |
511 | JINARC - 30 MG - COMPRESSA - USO ORALE - BLISTER (ALU/PVC) - 28 COMPRESSE | 1件: Tolvaptan Tolvaptan | 1件: Tolvaptan
Tolvaptan
💬 | 1件: AVPR2 AVPR2 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 1件: 67 67 💬 |
512 | JR-171 (lepunafusp alfa) | - | - | - | - | 1件: 19 19 💬 |
513 | L-3-(3,4-Dihydroxyphenyl)alanine | 1件: Alanine Alanine | 1件: Alanine
Alanine
💬 | - | - | 1件: 6 6 💬 |
514 | L-alanine | 1件: Alanine Alanine | 1件: Alanine
Alanine
💬 | - | - | 1件: 299 299 💬 |
515 | LARONIDASE (Aldurazyme (TN)) | 1件: Laronidase Laronidase (alpha-L-Idosiduronase) | 1件: Laronidase
Laronidase
(Aldurazyme (TN)) 💬 | 1件: IDUA IDUA 💬 | 3件: Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | 2件: 19 19, 256 💬 |
516 | Laronidase ERT (Aldurazyme (TN)) | 1件: Laronidase Laronidase (alpha-L-Idosiduronase) | 1件: Laronidase
Laronidase
(Aldurazyme (TN)) 💬 | 1件: IDUA IDUA 💬 | 3件: Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | 1件: 19 19 💬 |
517 | Laronidase therapy and a stem cell transplant (Aldurazyme (TN)) | 1件: Laronidase Laronidase (alpha-L-Idosiduronase) | 1件: Laronidase
Laronidase
(Aldurazyme (TN)) 💬 | 1件: IDUA IDUA 💬 | 3件: Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | 1件: 19 19 💬 |
518 | Lentivirus Alpha-gal A transduced stem cells | - | - | - | - | 1件: 19 19 💬 |
519 | Long term follow up in all patients who received SAR422459 in previous study TDU13583 | - | - | - | - | 1件: 301 301 💬 |
520 | Lovastatin (ALTOPREV) | 1件: Lovastatin Lovastatin (6-alpha-methylcompactin) | 1件: Lovastatin
Lovastatin
(ALTOPREV) 💬 | 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 11件: 6 6, 34, 46, 79, 156, 160, 195, 206, 263, 280, 310 💬 |
521 | Lovastatin 60 MG (ALTOPREV) | 1件: Lovastatin Lovastatin (6-alpha-methylcompactin) | 1件: Lovastatin
Lovastatin
(ALTOPREV) 💬 | 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 1件: 34 34 💬 |
522 | Lovastatin ™ (ALTOPREV) | 1件: Lovastatin Lovastatin (6-alpha-methylcompactin) | 1件: Lovastatin
Lovastatin
(ALTOPREV) 💬 | 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 1件: 34 34 💬 |
523 | Lovastatin, then Minocycline/Lovastatin (ALTOPREV) | 2件: Lovastatin Lovastatin (6-alpha-methylcompactin), Minocycline | 2件: Lovastatin
Lovastatin
(ALTOPREV),
Minocycline
💬 | 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 1件: 206 206 💬 |
524 | Low-dose Aldesleukin (Proleukin®) | 1件: Aldesleukin Aldesleukin | 1件: Aldesleukin
Aldesleukin
💬 | 3件: IL2RA IL2RA, IL2RB, IL2RG 💬 | 14件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 49 49 💬 |
525 | Magnesium gluconate (Almora (TN)) | 2件: Magnesium Magnesium (Alphaligo), Magnesium gluconate | 1件: Magnesium gluconate
Magnesium gluconate
(Almora (TN)) 💬 | - | - | 2件: 296 296, 297 💬 |
526 | MAVENCLAD - 10 MG - COMPRESSA - USO ORALE - BLISTER (AL/AL) - 6 COMPRESSE | 1件: Cladribine Cladribine | 1件: Cladribine
Cladribine
💬 | 1件: RRM1 RRM1 💬 | 6件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 13 13 💬 |
527 | Melphalan (Alkeran (TN)) | 1件: Melphalan Melphalan (Alkeran) | 1件: Melphalan
Melphalan
(Alkeran (TN)) 💬 | - | - | 15件: 11 11, 13, 14, 19, 20, 28, 60, 62, 65, 96, 164, 234, 284, 285, 299 💬 |
528 | Melphalan fulfenamide hydrochloride (Alkeran (TN)) | 1件: Melphalan Melphalan (Alkeran) | 1件: Melphalan
Melphalan
(Alkeran (TN)) 💬 | - | - | 1件: 28 28 💬 |
529 | Melphalan Hydrochloride (Alkeran (TN)) | 1件: Melphalan Melphalan (Alkeran) | 1件: Melphalan
Melphalan
(Alkeran (TN)) 💬 | - | - | 1件: 60 60 💬 |
530 | Melphalan, thalidomide and dexamethasone (Alkeran (TN)) | 3件: Dexamethasone Dexamethasone, Melphalan (Alkeran), Thalidomide (alpha-N-Phthalylglutaramide) | 3件: Dexamethasone
Dexamethasone
,
Melphalan
(Alkeran (TN)),
Thalidomide
💬 | 2件: NR3C1 NR3C1, TNF 💬 | 68件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 28 28 💬 |
531 | Melphalan-Flufenamide (Melflufen) (Alkeran (TN)) | 2件: Melphalan Melphalan (Alkeran), Melphalan flufenamide | 2件: Melphalan
Melphalan
(Alkeran (TN)),
Melphalan flufenamide
💬 | - | - | 1件: 28 28 💬 |
532 | Mesalazine 250Mg Tablet and nitazoxanide 500Mg Oral Tablet (Alinia (TN)) | 2件: Mesalazine Mesalazine, Nitazoxanide (Alinia) | 2件: Mesalamine
Mesalamine
,
Nitazoxanide
(Alinia (TN)) 💬 | - | - | 1件: 97 97 💬 |
533 | Mesalazine with hydrocortisone sodium succinate (ALKINDI) | 2件: Hydrocortisone Hydrocortisone (Meijer Anti-itch with Aloe), Mesalazine | 2件: Hydrocortisone
Hydrocortisone
(ALKINDI),
Mesalamine
💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 💬 |
534 | Methotrexate alone | 1件: Methotrexate Methotrexate | 1件: Methotrexate
Methotrexate
💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 107 107 💬 |
535 | Methotrexate plus ENBREL or ENBREL alone | 1件: Methotrexate Methotrexate | 1件: Methotrexate
Methotrexate
💬 | 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 💬 |
536 | METOCLOPRAMIDE ACCORD - 10 MG COMPRESSE 28 COMPRESSE IN BLISTER PVC/PVDC/AL | 1件: Metoclopramide Metoclopramide | 1件: Metoclopramide
Metoclopramide
💬 | 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 51 51 💬 |
537 | Minocycline, then Minocycline/Lovastatin (ALTOPREV) | 2件: Lovastatin Lovastatin (6-alpha-methylcompactin), Minocycline | 2件: Lovastatin
Lovastatin
(ALTOPREV),
Minocycline
💬 | 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 1件: 206 206 💬 |
538 | Moss-aGal (recombinant human alpha-galactosidase A produced in moss) | 1件: Agalsidase alfa Agalsidase alfa | 1件: Agalsidase alfa
Agalsidase alfa
💬 | 1件: GLA GLA 💬 | 6件: Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬 | 1件: 19 19 💬 |
539 | Myozyme® (alglucosidase alfa) | 1件: Alglucosidase alfa Alglucosidase alfa | 1件: Alglucosidase alfa
Alglucosidase alfa
💬 | 1件: GAA GAA 💬 | 4件: Galactose metabolism Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬 | 1件: 256 256 💬 |
540 | N. MENINGITIDIS GROUP C (STRAIN C11) OLIGOSACCHARIDE CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE CRM197 ADSORBED ON ALUMINUM HYDROXIDE | 5件: Aluminium Aluminium, Aluminum hydroxide, Corynebacterium diphtheriae, Corynebacterium diphtheriae CRM197 protein, Hydroxide ion | 1件: Aluminum hydroxide
Aluminum hydroxide
💬 | - | - | 1件: 11 11 💬 |
541 | Nab-sirolimus (also known as ABI-009, nab-rapamycin, albumin-bound rapamycin) | 1件: Sirolimus Sirolimus | 1件: Sirolimus
Sirolimus
💬 | 1件: MTOR MTOR 💬 | 51件: AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | 1件: 86 86 💬 |
542 | Nebulized combination ipratropium bromide with salbutamol (Albuterol) | 2件: Ipratropium Ipratropium (Ipratropium Bromide and Albuterol Sulfate), Salbutamol (Albuterol sulfate) | 1件: Albuterol
Albuterol
💬 | 1件: ADRB2 ADRB2 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬 |
543 | NeoGAA or avalglucosidase alfa | 1件: Avalglucosidase alfa Avalglucosidase alfa | 1件: Avalglucosidase alfa
Avalglucosidase alfa
💬 | 1件: GAA GAA 💬 | 4件: Galactose metabolism Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬 | 1件: 256 256 💬 |
544 | Nitazoxanide (Alinia (TN)) | 1件: Nitazoxanide Nitazoxanide (Alinia) | 1件: Nitazoxanide
Nitazoxanide
(Alinia (TN)) 💬 | - | - | 3件: 46 46, 96, 97 💬 |
545 | Nitazoxanide 500Mg Oral Tablet (Alinia (TN)) | 1件: Nitazoxanide Nitazoxanide (Alinia) | 1件: Nitazoxanide
Nitazoxanide
(Alinia (TN)) 💬 | - | - | 2件: 46 46, 97 💬 |
546 | Nle4-D-Phe7-alpha-MSH | - | - | - | - | 1件: 254 254 💬 |
547 | Obyoctocog alfa | - | - | - | - | 1件: 288 288 💬 |
548 | OCTOCOG ALFA | 1件: Antihemophilic factor, human recombinant Antihemophilic factor, human recombinant (Octocog alfa) | - | - | - | 1件: 288 288 💬 |
549 | OligoG-CF5/20, Alginate oligosaccharide (G-block) fragment | 1件: Alginic acid Alginic acid | 1件: Alginic acid
Alginic acid
💬 | - | - | 1件: 299 299 💬 |
550 | Oligomer of Sodium Alginate | 1件: Alginic acid Alginic acid | 1件: Alginic acid
Alginic acid
💬 | - | - | 1件: 299 299 💬 |
551 | OLIPUDASE ALFA | 1件: Olipudase alfa Olipudase alfa | 1件: Olipudase alfa
Olipudase alfa
💬 | 1件: SMPD1 SMPD1 💬 | 5件: Lysosome Lysosome, Metabolic pathways, Necroptosis, Sphingolipid metabolism, Sphingolipid signaling pathway 💬 | 1件: 19 19 💬 |
552 | Olipudase alfa (GZ402665) | 1件: Olipudase alfa Olipudase alfa | 1件: Olipudase alfa
Olipudase alfa
💬 | 1件: SMPD1 SMPD1 💬 | 5件: Lysosome Lysosome, Metabolic pathways, Necroptosis, Sphingolipid metabolism, Sphingolipid signaling pathway 💬 | 1件: 19 19 💬 |
553 | Olipudase alfa (rhASM) | 1件: Olipudase alfa Olipudase alfa | 1件: Olipudase alfa
Olipudase alfa
💬 | 1件: SMPD1 SMPD1 💬 | 5件: Lysosome Lysosome, Metabolic pathways, Necroptosis, Sphingolipid metabolism, Sphingolipid signaling pathway 💬 | 1件: 19 19 💬 |
554 | One Alpha | - | - | - | - | 2件: 50 50, 107 💬 |
555 | One Alpha Drops | - | - | - | - | 2件: 50 50, 107 💬 |
556 | One-alpha | 1件: Alfacalcidol Alfacalcidol | 1件: Alfacalcidol
Alfacalcidol
💬 | 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 2件: 50 50, 107 💬 |
557 | One-Alpha drops | 1件: Alfacalcidol Alfacalcidol | 1件: Alfacalcidol
Alfacalcidol
💬 | 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 2件: 50 50, 107 💬 |
558 | Open label - AL001 | 1件: Latozinemab Latozinemab (AL001) | 1件: Latozinemab
Latozinemab
💬 | 1件: SORT1 SORT1 💬 | 3件: Cholesterol metabolism Cholesterol metabolism, Lysosome, Neurotrophin signaling pathway 💬 | 1件: 127 127 💬 |
559 | Oral all-trans retinoic acid (ATRA) | 1件: Tretinoin Tretinoin (all--Retinoic acid) | 1件: Tretinoin
Tretinoin
(ALTRENO) 💬 | 3件: PML PML, RARA, RARB 💬 | 12件: Acute myeloid leukemia Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis 💬 | 1件: 94 94 💬 |
560 | Ornithine alpha ketoglutarate | 1件: Ornithine Ornithine | 1件: Ornithine
Ornithine
💬 | - | - | 1件: 245 245 💬 |
561 | OTEZLA - 10 MG + 20 MG + 30 MG COMPRESSA RIVESTITA CON FILM USO ORALE - BLISTER (PVC/ALU) IN UN ASTUCCIO - 4 COMPRESSE DA 10 MG + 4 COMPRESSE DA 20 MG +19 COMPRESSE DA 30 MG | 1件: Apremilast Apremilast | 1件: Apremilast
Apremilast
💬 | 4件: PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬 | 5件: Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | 2件: 56 56, 107 💬 |
562 | OTEZLA - 30 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PVC/ALU) - 56 COMPRESSE | 1件: Apremilast Apremilast | 1件: Apremilast
Apremilast
💬 | 4件: PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬 | 5件: Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | 1件: 107 107 💬 |
563 | Pabinafusp alfa | 1件: Pabinafusp alfa Pabinafusp alfa | 1件: Pabinafusp alfa
Pabinafusp alfa
💬 | 2件: IDS IDS, TFRC 💬 | 8件: Endocytosis Endocytosis, Ferroptosis, Glycosaminoglycan degradation, HIF-1 signaling pathway, Hematopoietic cell lineage, Lysosome, Metabolic pathways, Phagosome 💬 | 1件: 19 19 💬 |
564 | PARATHYROID HORMONE (ALX 1-11) | 1件: Parathyroid hormone Parathyroid hormone | 1件: Parathyroid hormone
Parathyroid hormone
(ALX 1-11) 💬 | 2件: PTH1R PTH1R, PTH2R 💬 | 3件: Endocrine and other factor-regulated calcium reabsorption Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬 | 2件: 70 70, 235 💬 |
565 | Parathyroid Hormone (1-84) Human Recombinant (ALX 1-11) | 1件: Parathyroid hormone Parathyroid hormone | 1件: Parathyroid hormone
Parathyroid hormone
(ALX 1-11) 💬 | 2件: PTH1R PTH1R, PTH2R 💬 | 3件: Endocrine and other factor-regulated calcium reabsorption Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬 | 1件: 235 235 💬 |
566 | Parathyroid Hormone (rDNA) (ALX 1-11) | 1件: Parathyroid hormone Parathyroid hormone | 1件: Parathyroid hormone
Parathyroid hormone
(ALX 1-11) 💬 | 2件: PTH1R PTH1R, PTH2R 💬 | 3件: Endocrine and other factor-regulated calcium reabsorption Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬 | 1件: 235 235 💬 |
567 | Part 2 Adult Alogabat High Dose (aged 15-17) | - | - | - | - | 1件: 201 201 💬 |
568 | Peg-Interferon alpha-2b | 1件: Interferon alfa-2b Interferon alfa-2b | 1件: Interferon alfa-2b
Interferon alfa-2b
💬 | 2件: IFNAR1 IFNAR1, IFNAR2 💬 | 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 34 34 💬 |
569 | PEGUNIGALSIDASE ALFA | 1件: Pegunigalsidase alfa Pegunigalsidase alfa | 1件: Pegunigalsidase alfa
Pegunigalsidase alfa
💬 | - | - | 1件: 19 19 💬 |
570 | Pegunigalsidase alpha | - | - | - | - | 1件: 19 19 💬 |
571 | Pegylated interferon alfa | 1件: Interferon alfa Interferon alfa | 1件: Interferon alfa
Interferon alfa
💬 | 2件: IFNAR1 IFNAR1, IFNAR2 💬 | 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 96 96 💬 |
572 | Pegylated Interferon Alpha2b | - | - | - | - | 1件: 227 227 💬 |
573 | PEGYLATED RECOMBINANT HUMAN HYALURONIDASE PH20 (Vorhyaluronidase alfa (genetical recombination) (JAN)) | 2件: Hyaluronidase Hyaluronidase, Hyaluronidase (human recombinant) (Vorhyaluronidase alfa) | 3件: Hyaluronidase
Hyaluronidase
,
Hyaluronidase
,
Hyaluronidase
(Vorhyaluronidase alfa (genetical recombination) (JAN)) 💬 | - | - | 1件: 28 28 💬 |
574 | PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE | 4件: Aluminium Aluminium, Aluminum hydroxide, Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated), Hydroxide ion | 1件: Aluminum hydroxide
Aluminum hydroxide
💬 | - | - | 1件: 46 46 💬 |
575 | PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE | 4件: Aluminium Aluminium, Aluminum hydroxide, Bordetella pertussis pertactin antigen, Hydroxide ion | 1件: Aluminum hydroxide
Aluminum hydroxide
💬 | - | - | 1件: 46 46 💬 |
576 | PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE | 4件: Aluminium Aluminium, Aluminum hydroxide, Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated), Hydroxide ion | 1件: Aluminum hydroxide
Aluminum hydroxide
💬 | - | - | 1件: 46 46 💬 |
577 | Pioglitazone and Tretinoin (ALTRENO) | 2件: Pioglitazone Pioglitazone (Alogliptin and Pioglitazone), Tretinoin (all--Retinoic acid) | 2件: Tretinoin
Tretinoin
(ALTRENO),
Pioglitazone
💬 | 4件: PML PML, PPARG, RARA, RARB 💬 | 21件: AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Huntington disease, Influenza A, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis 💬 | 1件: 2 2 💬 |
578 | PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE (13-VALENT, ADSORBED) CONJUGATED TO CRM197 CARRIER PROTEIN AND ADSORBED ON ALUMINIUM PHOSPHATE | 4件: Aluminium Aluminium, Aluminium phosphate, Corynebacterium diphtheriae CRM197 protein, Phosphate ion | - | - | - | 1件: 46 46 💬 |
579 | POLY(OXY-1,2-ETHANEDIYL), ALPHA-HYDRO-OMEGA-METHOXY, ETHER WITH N-[[[2- | 1件: Diethyl ether Diethyl ether | 1件: Ether
Ether
💬 | - | - | 1件: 235 235 💬 |
580 | POLY(OXY-1,2-ETHANEDIYL), ALPHA-HYDRO-OMEGA-METHOXY, ETHER WITH N-[[[2-[[6-[[1-[3-[[3-(2,3-DIHYDROXYPROPOXY)PROPYL]AMINO]-3-OXOPROPYL]-2,5-DI | 1件: Diethyl ether Diethyl ether | 1件: Ether
Ether
💬 | - | - | 1件: 235 235 💬 |
581 | POLY(OXY-1,2-ETHANEDIYL), ALPHA-HYDRO-OMEGA-METHOXY, ETHER WITH N-[[[2-[[6-[[1-[3-[[3-(2,3-DIHYDROXYPROPOXY)PROPYL]AMINO]-3-OXOPROPYL]-2,5-DIOXO-3-PYRROLIDINYL]THIO]HEXYL]AMINO]ETHYL]AMINO]CARBONYL]-2-METHYLALANYL-TERIPARATIDE (2:1) | 2件: Diethyl ether Diethyl ether, Teriparatide | 2件: Ether
Ether
,
Teriparatide
💬 | 1件: PTH1R PTH1R 💬 | 3件: Endocrine and other factor-regulated calcium reabsorption Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬 | 1件: 235 235 💬 |
582 | Positron Emission Tomography using [11 Carbon]-3-amino-4-(2-dimethylaminomethylphenylsulfanyl)-benzonitrile ([11C]-DASB) and [18 Fluorine]-altanserin ([18F]-altanserin) | 1件: Activated charcoal Activated charcoal | - | - | - | 1件: 6 6 💬 |
583 | Positron Emission Tomography using [18 Fluorine]-altanserin ([18F]-altanserin) | - | - | - | - | 1件: 6 6 💬 |
584 | Prednisone 0,5 mg/kg orally on alternate days | 1件: Prednisone Prednisone (Contrast Allergy PreMed Pack) | 1件: Prednisone
Prednisone
💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 222 222 💬 |
585 | Prednisone alone | 1件: Prednisone Prednisone (Contrast Allergy PreMed Pack) | 1件: Prednisone
Prednisone
💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 11 11, 66 💬 |
586 | PREDNISONE DOC GENERICI - 5 MG COMPRESSE 10 COMPRESSE IN BLISTER PVC-PVDC/ALU | 1件: Prednisone Prednisone (Contrast Allergy PreMed Pack) | 1件: Prednisone
Prednisone
💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 19 19 💬 |
587 | PREDNISONE DOC GENERICI - 5 MG COMPRESSE 30 COMPRESSE IN BLISTER PVC-PVDC/ALU | 1件: Prednisone Prednisone (Contrast Allergy PreMed Pack) | 1件: Prednisone
Prednisone
💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 300 300 💬 |
588 | Pridia (Donepezil Hydrochloride) 5mg (Allydone (TN)) | 1件: Donepezil Donepezil | 1件: Donepezil
Donepezil
(Allydone (TN)) 💬 | 1件: ACHE ACHE 💬 | 2件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | 1件: 6 6 💬 |
589 | Prior Donepezil 5mg (Allydone (TN)) | 1件: Donepezil Donepezil | 1件: Donepezil
Donepezil
(Allydone (TN)) 💬 | 1件: ACHE ACHE 💬 | 2件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | 1件: 6 6 💬 |
590 | PRM-151 (Zinpentraxin Alfa) | 1件: PRM-151 PRM-151 | - | - | - | 1件: 85 85 💬 |
591 | PRX-102 (pegunigalsidase alfa) | 1件: Pegunigalsidase alfa Pegunigalsidase alfa | 1件: Pegunigalsidase alfa
Pegunigalsidase alfa
💬 | - | - | 1件: 19 19 💬 |
592 | PRX002, ELT2, anti-alpha-synuclein monoclonal antibody | - | - | - | - | 1件: 6 6 💬 |
593 | Pulmozyme (dornase alfa) | 1件: Dornase alfa Dornase alfa | 1件: Dornase alfa
Dornase alfa
💬 | - | - | 1件: 299 299 💬 |
594 | Pulmozyme (Dornase alpha) | 1件: Dornase alfa Dornase alfa | 1件: Dornase alfa
Dornase alfa
💬 | - | - | 1件: 299 299 💬 |
595 | R-salbutamol (Albuterol) | 2件: Levosalbutamol Levosalbutamol (Albuterol), Salbutamol (Albuterol sulfate) | 2件: Albuterol
Albuterol
,
Levosalbutamol
💬 | 1件: ADRB2 ADRB2 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 49 49 💬 |
596 | R-salbutamol sulphate (Albuterol) | 2件: Levosalbutamol Levosalbutamol (Albuterol), Salbutamol (Albuterol sulfate) | 2件: Albuterol
Albuterol
,
Levosalbutamol
💬 | 1件: ADRB2 ADRB2 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 49 49 💬 |
597 | RAAV1.tMCK.human-alpha-sarcoglycan- First cohort | - | - | - | - | 1件: 113 113 💬 |
598 | RAAV1.tMCK.human-alpha-sarcoglycan- Second cohort | - | - | - | - | 1件: 113 113 💬 |
599 | Ramipril (Altace (TN)) | 1件: Ramipril Ramipril (Altace Cap 10mg) | 1件: Ramipril
Ramipril
(Altace (TN)) 💬 | 1件: ACE ACE 💬 | 6件: Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | 7件: 46 46, 49, 66, 67, 113, 218, 257 💬 |
600 | RANEXA - 750 MG - COMPRESSA A RILASCIO PROLUNGATO- USO ORALE - BLISTER (PVC/PVDC/ALLUMINIO) 60 COMPRESSE | 1件: Ranolazine Ranolazine | 1件: Ranolazine
Ranolazine
💬 | - | - | 1件: 58 58 💬 |
601 | Rapamicina tópica al 1% y excipiente | - | - | - | - | 1件: 157 157 💬 |
602 | Rcombinant Human Parathyroid Hormone [rhPTH(1-84)] (ALX 1-11) | 1件: Parathyroid hormone Parathyroid hormone | 1件: Parathyroid hormone
Parathyroid hormone
(ALX 1-11) 💬 | 2件: PTH1R PTH1R, PTH2R 💬 | 3件: Endocrine and other factor-regulated calcium reabsorption Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬 | 1件: 235 235 💬 |
603 | RECOMBINANT ADENO-ASSOCIATED VIRAL VECTOR EXPRESSING THE HUMAN ALPHA-1-ANTITRYPSIN GENE | 1件: Alpha-1-proteinase inhibitor Alpha-1-proteinase inhibitor | - | - | - | 1件: 231 231 💬 |
604 | Recombinant Adeno-associated virus 2/6 vector encoding the cDNA for human alpha galactosidase A | - | - | - | - | 1件: 19 19 💬 |
605 | Recombinant Adeno-Associated Virus Acid Alpha-Glucosidase | 1件: Alglucosidase alfa Alglucosidase alfa | 1件: Alglucosidase alfa
Alglucosidase alfa
💬 | 1件: GAA GAA 💬 | 4件: Galactose metabolism Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬 | 1件: 256 256 💬 |
606 | Recombinant alpha-galactosidase A | 1件: Agalsidase alfa Agalsidase alfa | 1件: Agalsidase alfa
Agalsidase alfa
💬 | 1件: GLA GLA 💬 | 6件: Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬 | 1件: 19 19 💬 |
607 | Recombinant human a-glucosidase conjugated with multiple copies of synthetic bis-mannose-6-phosphate-tetra-mannose glycan Avalglucosidase Alfa (NeoGAA) | 3件: Avalglucosidase alfa Avalglucosidase alfa, Mannose, Phosphate ion | 1件: Avalglucosidase alfa
Avalglucosidase alfa
💬 | 1件: GAA GAA 💬 | 4件: Galactose metabolism Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬 | 1件: 256 256 💬 |
608 | Recombinant human acid alfa-glucosidase | - | - | - | - | 1件: 256 256 💬 |
609 | Recombinant human acid alfa-glucosidase (ATB200) | - | - | - | - | 1件: 256 256 💬 |
610 | Recombinant human acid alfa-glucosidase (rhGAA) | - | - | - | - | 1件: 256 256 💬 |
611 | Recombinant human acid alpha-glucosidase (rhGAA) | 1件: Alglucosidase alfa Alglucosidase alfa | 1件: Alglucosidase alfa
Alglucosidase alfa
💬 | 1件: GAA GAA 💬 | 4件: Galactose metabolism Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬 | 1件: 256 256 💬 |
612 | RECOMBINANT HUMAN ALFA-GLUCOSIDASE CONJUGATED WITH SYNTHETIC BISMANNOSE-6-PHOSPHATE-MAN6 GLYCAN | 1件: Phosphate ion Phosphate ion | - | - | - | 1件: 256 256 💬 |
613 | Recombinant human alpha B-crystallin | - | - | - | - | 1件: 13 13 💬 |
614 | Recombinant human alpha-galactosidase | - | - | - | - | 1件: 19 19 💬 |
615 | Recombinant human alpha-galactosidase abbreviated as r-h-alpha-GAL | - | - | - | - | 1件: 19 19 💬 |
616 | Recombinant human alpha-mannosidase | - | - | - | - | 1件: 19 19 💬 |
617 | Recombinant Human Alpha-N-Acetylglucosaminidase (rhNAGLU) | - | - | - | - | 1件: 19 19 💬 |
618 | Recombinant human hyaluronidase (Vorhyaluronidase alfa (genetical recombination) (JAN)) | 2件: Hyaluronidase Hyaluronidase, Hyaluronidase (human recombinant) (Vorhyaluronidase alfa) | 3件: Hyaluronidase
Hyaluronidase
,
Hyaluronidase
,
Hyaluronidase
(Vorhyaluronidase alfa (genetical recombination) (JAN)) 💬 | - | - | 3件: 14 14, 28, 65 💬 |
619 | Recombinant Human Hyaluronidase (rHuPH20) (Vorhyaluronidase alfa (genetical recombination) (JAN)) | 2件: Hyaluronidase Hyaluronidase, Hyaluronidase (human recombinant) (Vorhyaluronidase alfa) | 3件: Hyaluronidase
Hyaluronidase
,
Hyaluronidase
,
Hyaluronidase
(Vorhyaluronidase alfa (genetical recombination) (JAN)) 💬 | - | - | 1件: 65 65 💬 |
620 | Recombinant human hyaluronidase (rHuPH20)+ immune globulin intravenous (IGIV) (Vorhyaluronidase alfa (genetical recombination) (JAN)) | 2件: Hyaluronidase Hyaluronidase, Hyaluronidase (human recombinant) (Vorhyaluronidase alfa) | 3件: Hyaluronidase
Hyaluronidase
,
Hyaluronidase
,
Hyaluronidase
(Vorhyaluronidase alfa (genetical recombination) (JAN)) 💬 | - | - | 1件: 65 65 💬 |
621 | Recombinant human hyaluronidase + immune globulin intravenous (Vorhyaluronidase alfa (genetical recombination) (JAN)) | 2件: Hyaluronidase Hyaluronidase, Hyaluronidase (human recombinant) (Vorhyaluronidase alfa) | 3件: Hyaluronidase
Hyaluronidase
,
Hyaluronidase
,
Hyaluronidase
(Vorhyaluronidase alfa (genetical recombination) (JAN)) 💬 | - | - | 1件: 65 65 💬 |
622 | Recombinant human hyaluronidase PH20 (Vorhyaluronidase alfa (genetical recombination) (JAN)) | 2件: Hyaluronidase Hyaluronidase, Hyaluronidase (human recombinant) (Vorhyaluronidase alfa) | 3件: Hyaluronidase
Hyaluronidase
,
Hyaluronidase
,
Hyaluronidase
(Vorhyaluronidase alfa (genetical recombination) (JAN)) 💬 | - | - | 1件: 28 28 💬 |
623 | Recombinant human lysosomal alpha-mannosidase | - | - | - | - | 1件: 19 19 💬 |
624 | RECOMBINANT HUMAN PARATHYROID HORMONE (1-84) (ALX 1-11) | 1件: Parathyroid hormone Parathyroid hormone | 1件: Parathyroid hormone
Parathyroid hormone
(ALX 1-11) 💬 | 2件: PTH1R PTH1R, PTH2R 💬 | 3件: Endocrine and other factor-regulated calcium reabsorption Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬 | 1件: 235 235 💬 |
625 | Recombinant Human Parathyroid Hormone [rhPTH(1-84)] (ALX 1-11) | 1件: Parathyroid hormone Parathyroid hormone | 1件: Parathyroid hormone
Parathyroid hormone
(ALX 1-11) 💬 | 2件: PTH1R PTH1R, PTH2R 💬 | 3件: Endocrine and other factor-regulated calcium reabsorption Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬 | 1件: 235 235 💬 |
626 | RECOMBINANT HUMAN SERUM ALBUMIN (HSA) FUSED TO HUMAN GROWTH HORMONE (HGH) | 2件: Albumin human Albumin human, Somatotropin | 1件: Albumin human
Albumin human
💬 | - | - | 1件: 78 78 💬 |
627 | Recombinant humanized anti-alpha 4 integrin antibody | - | - | - | - | 1件: 13 13 💬 |
628 | Recombinant interferon alfa | 1件: Interferon alfa Interferon alfa | 1件: Interferon alfa
Interferon alfa
💬 | 2件: IFNAR1 IFNAR1, IFNAR2 💬 | 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 2件: 26 26, 28 💬 |
629 | RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E.COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE | 5件: Aluminium Aluminium, Aluminum hydroxide, Hydroxide ion, Iron polymaltose, Lactobacillus casei | 2件: Aluminum hydroxide
Aluminum hydroxide
,
Lactobacillus casei
💬 | - | - | 1件: 11 11 💬 |
630 | Replagal (Agalsidase Alfa) | 1件: Agalsidase alfa Agalsidase alfa | 1件: Agalsidase alfa
Agalsidase alfa
💬 | 1件: GLA GLA 💬 | 6件: Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬 | 1件: 19 19 💬 |
631 | Replagal agalsidase alfa | 1件: Agalsidase alfa Agalsidase alfa | 1件: Agalsidase alfa
Agalsidase alfa
💬 | 1件: GLA GLA 💬 | 6件: Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬 | 1件: 19 19 💬 |
632 | Reveglucosidase alfa | - | - | - | - | 1件: 256 256 💬 |
633 | Reveglucosidase alpha | - | - | - | - | 1件: 256 256 💬 |
634 | REVOLADE - 25 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER(PA/ALU/PVC/ALU) 28 COMPRESSE | 1件: Eltrombopag Eltrombopag | - | - | - | 1件: 60 60 💬 |
635 | REVOLADE - 50 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER(PA/ALU/PVC/ALU | 1件: Eltrombopag Eltrombopag | - | - | - | 1件: 60 60 💬 |
636 | RhGAA, acid alpha glucosidase | - | - | - | - | 1件: 256 256 💬 |
637 | RhIDU (recombinant human-Alpha-L-Iduronidase) | - | - | - | - | 1件: 19 19 💬 |
638 | RIC alloBMT w PTCy in refractory SSc | - | - | - | - | 1件: 51 51 💬 |
639 | RILUZOLO TEVA - 50 MG COMPRESSE RIVESTITE CON FILM 90 COMPRESSE IN BLISTER AL/PVC | - | - | - | - | 1件: 114 114 💬 |
640 | Rituximab and Hyaluronidase Human (Vorhyaluronidase alfa (genetical recombination) (JAN)) | 2件: Hyaluronidase Hyaluronidase, Rituximab | 4件: Rituximab
Rituximab
,
Hyaluronidase
,
Hyaluronidase
,
Hyaluronidase
(Vorhyaluronidase alfa (genetical recombination) (JAN)) 💬 | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 331 331 💬 |
641 | Rozibafusp Alfa | - | - | - | - | 1件: 49 49 💬 |
642 | Rurioctocog alfa pegol | 1件: Rurioctocog alfa pegol Rurioctocog alfa pegol | 1件: Rurioctocog alfa pegol
Rurioctocog alfa pegol
💬 | - | - | 1件: 288 288 💬 |
643 | S.c. injections of bovine intestinal Alkaline Phosphatase | 1件: Alkaline Phosphatase Alkaline Phosphatase | - | - | - | 1件: 46 46 💬 |
644 | Salbutamol (Albuterol) | 1件: Salbutamol Salbutamol (Albuterol sulfate) | 1件: Albuterol
Albuterol
💬 | 1件: ADRB2 ADRB2 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 8件: 3 3, 11, 49, 85, 86, 111, 256, 299 💬 |
645 | Salbutamol (as Salbutamol Sulfate) 2 Mg Oral Tablet (Albuterol) | 2件: Salbutamol Salbutamol (Albuterol sulfate), Sulfate ion | 1件: Albuterol
Albuterol
💬 | 1件: ADRB2 ADRB2 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 111 111 💬 |
646 | Salbutamol 4Mg Tablet (Albuterol) | 1件: Salbutamol Salbutamol (Albuterol sulfate) | 1件: Albuterol
Albuterol
💬 | 1件: ADRB2 ADRB2 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 11 11 💬 |
647 | Salbutamol Only Product in Oral Dose Form (Albuterol) | 1件: Salbutamol Salbutamol (Albuterol sulfate) | 1件: Albuterol
Albuterol
💬 | 1件: ADRB2 ADRB2 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 111 111 💬 |
648 | SALBUTAMOL SULFATE (Albuterol) | 2件: Salbutamol Salbutamol (Albuterol sulfate), Sulfate ion | 1件: Albuterol
Albuterol
💬 | 1件: ADRB2 ADRB2 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 111 111 💬 |
649 | SALBUTAMOL SULFATE PH. EUR. (Albuterol) | 2件: Salbutamol Salbutamol (Albuterol sulfate), Sulfate ion | 1件: Albuterol
Albuterol
💬 | 1件: ADRB2 ADRB2 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 11 11 💬 |
650 | Salbutamol WZF 4 mg (Albuterol) | 1件: Salbutamol Salbutamol (Albuterol sulfate) | 1件: Albuterol
Albuterol
💬 | 1件: ADRB2 ADRB2 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 11 11 💬 |
651 | Salbutamol-ratiopharm® N metered-dose aerosol inhaler (Albuterol) | 1件: Salbutamol Salbutamol (Albuterol sulfate) | 1件: Albuterol
Albuterol
💬 | 1件: ADRB2 ADRB2 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 299 299 💬 |
652 | Salbutamol-ratiopharm® N metereddose aerosol inhaler (Albuterol) | 1件: Salbutamol Salbutamol (Albuterol sulfate) | 1件: Albuterol
Albuterol
💬 | 1件: ADRB2 ADRB2 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 299 299 💬 |
653 | Sebelipasa Alfa | 1件: Sebelipase alfa Sebelipase alfa | 1件: Sebelipase alfa
Sebelipase alfa
💬 | 1件: LIPA LIPA 💬 | 3件: Cholesterol metabolism Cholesterol metabolism, Lysosome, Steroid biosynthesis 💬 | 1件: 19 19 💬 |
654 | Sebelipase Alfa | 1件: Sebelipase alfa Sebelipase alfa | 1件: Sebelipase alfa
Sebelipase alfa
💬 | 1件: LIPA LIPA 💬 | 3件: Cholesterol metabolism Cholesterol metabolism, Lysosome, Steroid biosynthesis 💬 | 1件: 19 19 💬 |
655 | Sebelipase alfa (SBC-102) | 1件: Sebelipase alfa Sebelipase alfa | 1件: Sebelipase alfa
Sebelipase alfa
💬 | 1件: LIPA LIPA 💬 | 3件: Cholesterol metabolism Cholesterol metabolism, Lysosome, Steroid biosynthesis 💬 | 1件: 19 19 💬 |
656 | Sebelipase alfa 0.35 mg/kg | 1件: Sebelipase alfa Sebelipase alfa | 1件: Sebelipase alfa
Sebelipase alfa
💬 | 1件: LIPA LIPA 💬 | 3件: Cholesterol metabolism Cholesterol metabolism, Lysosome, Steroid biosynthesis 💬 | 1件: 19 19 💬 |
657 | Sebelipase alfa 1 mg/kg | 1件: Sebelipase alfa Sebelipase alfa | 1件: Sebelipase alfa
Sebelipase alfa
💬 | 1件: LIPA LIPA 💬 | 3件: Cholesterol metabolism Cholesterol metabolism, Lysosome, Steroid biosynthesis 💬 | 1件: 19 19 💬 |
658 | Sebelipase alfa 3 mg/kg | 1件: Sebelipase alfa Sebelipase alfa | 1件: Sebelipase alfa
Sebelipase alfa
💬 | 1件: LIPA LIPA 💬 | 3件: Cholesterol metabolism Cholesterol metabolism, Lysosome, Steroid biosynthesis 💬 | 1件: 19 19 💬 |
659 | Serum albumin | 1件: Albumin human Albumin human | 1件: Albumin human
Albumin human
💬 | - | - | 1件: 78 78 💬 |
660 | SERUM ALBUMINE 5% | - | - | - | - | 1件: 96 96 💬 |
661 | Sezione * D.3.6.2.1 - valore: 400mg alla settimana 0, in seguito 200mg ogni due settimane | - | - | - | - | 1件: 96 96 💬 |
662 | Simvastatin Alternova | 1件: Simvastatin Simvastatin | 1件: Simvastatin
Simvastatin
💬 | 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 1件: 13 13 💬 |
663 | Sitaxsentan alone | 1件: Sitaxentan Sitaxentan | 1件: Sitaxentan
Sitaxentan
💬 | 1件: EDNRA EDNRA 💬 | 7件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬 |
664 | SODIUM ALGINATE | 1件: Alginic acid Alginic acid | 1件: Alginic acid
Alginic acid
💬 | - | - | 1件: 299 299 💬 |
665 | Solu-Cortef (hydrocortisone) (ALKINDI) | 1件: Hydrocortisone Hydrocortisone (Meijer Anti-itch with Aloe) | 1件: Hydrocortisone
Hydrocortisone
(ALKINDI) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 83 83 💬 |
666 | Spironolactone (Aldactone (TN)) | 1件: Spironolactone Spironolactone (Aldactone 100 mg) | 1件: Spironolactone
Spironolactone
(Aldactone (TN)) 💬 | 1件: NR3C2 NR3C2 💬 | 1件: Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption 💬 | 8件: 46 46, 58, 67, 86, 113, 210, 218, 225 💬 |
667 | Spironolactone (drug) (Aldactone (TN)) | 1件: Spironolactone Spironolactone (Aldactone 100 mg) | 1件: Spironolactone
Spironolactone
(Aldactone (TN)) 💬 | 1件: NR3C2 NR3C2 💬 | 1件: Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption 💬 | 1件: 210 210 💬 |
668 | Spironolactone and conivaptan (Aldactone (TN)) | 2件: Conivaptan Conivaptan, Spironolactone (Aldactone 100 mg) | 2件: Spironolactone
Spironolactone
(Aldactone (TN)),
Conivaptan
💬 | 3件: AVPR1A AVPR1A, AVPR2, NR3C2 💬 | 6件: Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption 💬 | 1件: 86 86 💬 |
669 | Spironolactone captopril carvedilol (Aldactone (TN)) | 3件: Captopril Captopril, Carvedilol, Spironolactone (Aldactone 100 mg) | 3件: Captopril
Captopril
,
Carvedilol
,
Spironolactone
(Aldactone (TN)) 💬 | 7件: ACE ACE, ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2, NR3C2 💬 | 19件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone-regulated sodium reabsorption, Calcium signaling pathway, Chagas disease, Chemical carcinogenesis - receptor activation, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Dilated cardiomyopathy, Gap junction, Hypertrophic cardiomyopathy, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Renin-angiotensin system, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬 |
670 | Subcutaneous hydrocortisone 10mg (ALKINDI) | 1件: Hydrocortisone Hydrocortisone (Meijer Anti-itch with Aloe) | 1件: Hydrocortisone
Hydrocortisone
(ALKINDI) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 6 6 💬 |
671 | Submucosal Bevacizumab (ALYMSYS) | 1件: Bevacizumab Bevacizumab (Alymsys) | 1件: Bevacizumab
Bevacizumab
(ALYMSYS) 💬 | 1件: VEGFA VEGFA 💬 | 24件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬 | 1件: 227 227 💬 |
672 | Symptomatic treatment (Converting Enzyme inhibitor, Angiotensin II, Anti-renin, Aldosterone antagonist diuretic, Beta blocker, Calcium inhibitor, statin) | 3件: Aldosterone Aldosterone, Angiotensin II, Calcium (P D All) | 3件: Angiotensin II
Angiotensin II
,
Angiotensin II
,
Aldosterone
💬 | 3件: AGTR1 AGTR1, AGTR2, NR3C2 💬 | 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 222 222 💬 |
673 | Synthetic Human Parathyroid Hormone 1-34 (ALX 1-11) | 1件: Parathyroid hormone Parathyroid hormone | 1件: Parathyroid hormone
Parathyroid hormone
(ALX 1-11) 💬 | 2件: PTH1R PTH1R, PTH2R 💬 | 3件: Endocrine and other factor-regulated calcium reabsorption Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬 | 1件: 235 235 💬 |
674 | TADALAFIL (ALYQ) | 1件: Tadalafil Tadalafil (Alyq) | 1件: Tadalafil
Tadalafil
(ALYQ) 💬 | 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 7件: 6 6, 51, 75, 84, 86, 113, 210 💬 |
675 | Tadalafil 20 MG (ALYQ) | 1件: Tadalafil Tadalafil (Alyq) | 1件: Tadalafil
Tadalafil
(ALYQ) 💬 | 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 113 113 💬 |
676 | Tadalafil 20 mg film-coated tablets (ALYQ) | 1件: Tadalafil Tadalafil (Alyq) | 1件: Tadalafil
Tadalafil
(ALYQ) 💬 | 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬 |
677 | Tadalafil 40 mg (ALYQ) | 1件: Tadalafil Tadalafil (Alyq) | 1件: Tadalafil
Tadalafil
(ALYQ) 💬 | 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬 |
678 | Tadalafil and ambrisentan upfront combination therapy (ALYQ) | 2件: Ambrisentan Ambrisentan, Tadalafil (Alyq) | 2件: Tadalafil
Tadalafil
(ALYQ),
Ambrisentan
💬 | 2件: EDNRA EDNRA, PDE5A 💬 | 9件: Calcium signaling pathway Calcium signaling pathway, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 2件: 51 51, 86 💬 |
679 | Tadalafil and Sildenafil (ALYQ) | 2件: Sildenafil Sildenafil, Tadalafil (Alyq) | 2件: Tadalafil
Tadalafil
(ALYQ),
Sildenafil
💬 | 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 113 113 💬 |
680 | Tadalafil Citrate (ALYQ) | 1件: Tadalafil Tadalafil (Alyq) | 1件: Tadalafil
Tadalafil
(ALYQ) 💬 | 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 210 210 💬 |
681 | Tadalafil oral suspension (ALYQ) | 1件: Tadalafil Tadalafil (Alyq) | 1件: Tadalafil
Tadalafil
(ALYQ) 💬 | 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬 |
682 | Tadalafil- Tablet or Oral suspension (ALYQ) | 1件: Tadalafil Tadalafil (Alyq) | 1件: Tadalafil
Tadalafil
(ALYQ) 💬 | 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬 |
683 | TADEKINIG ALFA | 1件: Tadekinig alfa Tadekinig alfa | - | - | - | 1件: 65 65 💬 |
684 | Taldefgrobep alfa | 1件: Talditercept alfa Talditercept alfa | 1件: Taldefgrobep alfa
Taldefgrobep alfa
💬 | 1件: MSTN MSTN 💬 | 1件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬 | 1件: 3 3 💬 |
685 | TALIGLUCERASE ALFA | 1件: Taliglucerase alfa Taliglucerase alfa | 1件: Taliglucerase alfa
Taliglucerase alfa
💬 | 1件: GBA1 GBA1 💬 | 4件: Lysosome Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬 | 1件: 19 19 💬 |
686 | Taliglucerase alfa - Recombinant human glucocerebrosidase | 1件: Taliglucerase alfa Taliglucerase alfa | 1件: Taliglucerase alfa
Taliglucerase alfa
💬 | 1件: GBA1 GBA1 💬 | 4件: Lysosome Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬 | 1件: 19 19 💬 |
687 | TECFIDERA - 240 MG - CAPSULA RIGIDA GASTRORESISTENTE - USO ORALE - BLISTER (PVC/PE/PVDC-PVC ALLUMINIO) - 56 CAPSULE | - | - | - | - | 1件: 13 13 💬 |
688 | Teduglutide (ALX-0600) | 1件: Teduglutide Teduglutide | 1件: Teduglutide
Teduglutide
💬 | 1件: GLP2R GLP2R 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 96 96 💬 |
689 | Tenofovir alafenamide | 2件: Tenofovir Tenofovir, Tenofovir alafenamide | 2件: Tenofovir
Tenofovir
,
Tenofovir alafenamide
💬 | - | - | 2件: 2 2, 13 💬 |
690 | Tenofovir alafenamide (TAF) | 2件: Tenofovir Tenofovir, Tenofovir alafenamide | 2件: Tenofovir
Tenofovir
,
Tenofovir alafenamide
💬 | - | - | 1件: 2 2 💬 |
691 | TENOFOVIR ALAFENAMIDE FUMARATE 25 Mg ORAL TABLET [VEMLIDY] | 2件: Tenofovir Tenofovir, Tenofovir alafenamide | 2件: Tenofovir
Tenofovir
,
Tenofovir alafenamide
💬 | - | - | 1件: 13 13 💬 |
692 | Teriparatide [rDNA origin] contains recombinant human parathyroid hormone (1-34) (ALX 1-11) | 2件: Parathyroid hormone Parathyroid hormone, Teriparatide | 2件: Parathyroid hormone
Parathyroid hormone
(ALX 1-11),
Teriparatide
💬 | 2件: PTH1R PTH1R, PTH2R 💬 | 3件: Endocrine and other factor-regulated calcium reabsorption Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬 | 1件: 70 70 💬 |
693 | Tetanus + pnemococcal vaccines alone | - | - | - | - | 1件: 46 46 💬 |
694 | THALIDOMIDE CELGENE - 50 MG CAPSULA RIGIDA - USO ORALE - BLISTER (PVC/PE/ACLAR/ALU) 28 CAPSULE | 1件: Thalidomide Thalidomide (alpha-N-Phthalylglutaramide) | 1件: Thalidomide
Thalidomide
💬 | 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 💬 |
695 | Therapeutic Allogeneic Lymphocytes | - | - | - | - | 3件: 60 60, 65, 285 💬 |
696 | Thrombomodulin Alfa | 1件: Thrombomodulin Alfa Thrombomodulin Alfa | 1件: Thrombomodulin alfa
Thrombomodulin alfa
💬 | 1件: F2 F2 💬 | 8件: Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, Neuroactive ligand-receptor interaction, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Regulation of actin cytoskeleton 💬 | 1件: 85 85 💬 |
697 | Thymosin alpha 1 | - | - | - | - | 1件: 299 299 💬 |
698 | Timolol Alcon 0.5% collyre | 1件: Timolol Timolol | 2件: Timolol
Timolol
,
Timolol
💬 | 2件: ADRB1 ADRB1, ADRB2 💬 | 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 227 227 💬 |
699 | TNF alpha | - | - | - | - | 1件: 271 271 💬 |
700 | TNF alpha blockers | - | - | - | - | 1件: 46 46 💬 |
701 | TNF alpha inhibitors | - | - | - | - | 1件: 46 46 💬 |
702 | TNF-alpha antagonist and other biotherapy | - | - | - | - | 1件: 46 46 💬 |
703 | TNF-alpha antagonists | - | - | - | - | 3件: 46 46, 96, 271 💬 |
704 | TNF-alpha Inhibitor | - | - | - | - | 1件: 46 46 💬 |
705 | TOBI PODHALER - 28 MG POLVERE PER INALAZIONE CAPSULA RIGIDA USO INALATORIO BLISTER(ALU/ALU) 56 CAPSULE + 1 INALATORE | 1件: Tobramycin Tobramycin (O-3-Amino-3-deoxy-alpha-D-glucopyranosyl--2-deoxy-D-streptamine) | 1件: Tobramycin
Tobramycin
💬 | - | - | 1件: 299 299 💬 |
706 | Tocopherol (dl-alpha-Tocopherol) | 1件: Tocopherol Tocopherol (Aloe Vera Sprayer) | 1件: Tocopherol
Tocopherol
(dl-alpha-Tocopherol) 💬 | - | - | 5件: 13 13, 49, 206, 257, 298 💬 |
707 | Tocopherol (vit E) (dl-alpha-Tocopherol) | 1件: Tocopherol Tocopherol (Aloe Vera Sprayer) | 1件: Tocopherol
Tocopherol
(dl-alpha-Tocopherol) 💬 | - | - | 1件: 257 257 💬 |
708 | Tocopherol acetate (dl-alpha-Tocopherol) | 3件: Acetate Acetate, Tocopherol (Aloe Vera Sprayer), alpha-Tocopherol acetate | 1件: Tocopherol
Tocopherol
(dl-alpha-Tocopherol) 💬 | - | - | 1件: 49 49 💬 |
709 | Tralesinidase alfa | - | - | - | - | 1件: 19 19 💬 |
710 | Transplant Conditioning with Mobilization and Alemtuzumab | 1件: Alemtuzumab Alemtuzumab | 1件: Alemtuzumab
Alemtuzumab
💬 | 1件: CD52 CD52 💬 | - | 1件: 65 65 💬 |
711 | Transplant preparative regimen of alemtuzumab, fludarabine, thiotepa, and melphalan | 4件: Alemtuzumab Alemtuzumab, Fludarabine, Melphalan (Alkeran), Thiotepa | 4件: Melphalan
Melphalan
(Alkeran (TN)),
Thiotepa
,
Alemtuzumab
,
Fludarabine
💬 | 2件: CD52 CD52, RRM1 💬 | 6件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 2件: 65 65, 164 💬 |
712 | Treatment Algorithm A | - | - | - | - | 1件: 97 97 💬 |
713 | Treatment Algorithm B | - | - | - | - | 1件: 97 97 💬 |
714 | Treatment Algorithm C | - | - | - | - | 1件: 97 97 💬 |
715 | Tretinoin (ALTRENO) | 1件: Tretinoin Tretinoin (all--Retinoic acid) | 1件: Tretinoin
Tretinoin
(ALTRENO) 💬 | 3件: PML PML, RARA, RARB 💬 | 12件: Acute myeloid leukemia Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis 💬 | 3件: 2 2, 62, 75 💬 |
716 | Tretinoin and Pioglitazone HCL (ALTRENO) | 2件: Pioglitazone Pioglitazone (Alogliptin and Pioglitazone), Tretinoin (all--Retinoic acid) | 2件: Tretinoin
Tretinoin
(ALTRENO),
Pioglitazone
💬 | 4件: PML PML, PPARG, RARA, RARB 💬 | 21件: AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Huntington disease, Influenza A, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis 💬 | 1件: 2 2 💬 |
717 | Umbilical Cord Based Allogenic Mesenchymal Stem Cell | - | - | - | - | 1件: 113 113 💬 |
718 | UN-ALPHA-R | - | - | - | - | 1件: 235 235 💬 |
719 | UN-ALPHA-R 0.25µg | - | - | - | - | 1件: 235 235 💬 |
720 | USAN: sebelipasa alfa | 1件: Sebelipase alfa Sebelipase alfa | 1件: Sebelipase alfa
Sebelipase alfa
💬 | 1件: LIPA LIPA 💬 | 3件: Cholesterol metabolism Cholesterol metabolism, Lysosome, Steroid biosynthesis 💬 | 1件: 19 19 💬 |
721 | USAN: sebelipase alpha | - | - | - | - | 1件: 19 19 💬 |
722 | VELAGLUCERASE ALFA | 1件: Velaglucerase alfa Velaglucerase alfa | 1件: Velaglucerase alfa
Velaglucerase alfa
💬 | 1件: GBA1 GBA1 💬 | 4件: Lysosome Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬 | 1件: 19 19 💬 |
723 | Velaglucerasi alfa | - | - | - | - | 1件: 19 19 💬 |
724 | VELMANASE ALFA | 1件: Velmanase alfa Velmanase alfa | 1件: Velmanase alfa
Velmanase alfa
💬 | 1件: MAN2B1 MAN2B1 💬 | 2件: Lysosome Lysosome, Other glycan degradation 💬 | 1件: 19 19 💬 |
725 | Velmanase Alfa (e.g. Lamazym) | 1件: Velmanase alfa Velmanase alfa | 1件: Velmanase alfa
Velmanase alfa
💬 | 1件: MAN2B1 MAN2B1 💬 | 2件: Lysosome Lysosome, Other glycan degradation 💬 | 1件: 19 19 💬 |
726 | Vestronidase alfa | 1件: Vestronidase alfa Vestronidase alfa | 1件: Vestronidase alfa
Vestronidase alfa
💬 | 1件: GUSB GUSB 💬 | 8件: Ascorbate and aldarate metabolism Ascorbate and aldarate metabolism, Biosynthesis of cofactors, Drug metabolism - other enzymes, Glycosaminoglycan degradation, Lysosome, Metabolic pathways, Pentose and glucuronate interconversions, Porphyrin metabolism 💬 | 1件: 19 19 💬 |
727 | Vimizim® (elosulfase alfa) | 1件: Elosulfase alfa Elosulfase alfa | 1件: Elosulfase alfa
Elosulfase alfa
💬 | 1件: GALNS GALNS 💬 | 3件: Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | 1件: 19 19 💬 |
728 | VIUSID/ALZER | - | - | - | - | 1件: 6 6 💬 |
729 | Voltarol SR (generics also available in the EU) | - | - | - | - | 1件: 46 46 💬 |
730 | VONICOG ALFA | 1件: Vonicog alfa Vonicog alfa | 1件: Vonicog alfa
Vonicog alfa
💬 | - | - | 1件: 288 288 💬 |
731 | XADAGO - 100 MG- COMPRESSA RIVESTITA CON FILM- USO ORALE- BLISTER (PVC/PVDC/ALLUMINIO)- 30 COMPRESSE | 1件: Safinamide Safinamide | 1件: Safinamide
Safinamide
💬 | 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬 |
732 | XADAGO - 50 MG- COMPRESSA RIVESTITA CON FILM- USO ORALE- BLISTER (PVC/PVDC/ALLUMINIO)- 30 COMPRESSE | 1件: Safinamide Safinamide | 1件: Safinamide
Safinamide
💬 | 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬 |
733 | XCEL-MC-ALPHA | - | - | - | - | 1件: 13 13 💬 |
734 | Zinpetraxin Alfa | - | - | - | - | 1件: 85 85 💬 |
735 | ZUGLIMET - 500 MG COMPRESSE RIVESTITE CON FILM 30 COMPRESSE IN BLISTER PVC/AL | - | - | - | - | 1件: 67 67 💬 |